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ABSTRACT 
 Bovine adenovirus (BAdV)-3, a Mastadenovirus was isolated from the healthy and sick 
cattle (Darbyshire et al., 1965; Zhu et al., 2011). Like other adenoviruses, BAdV-3 replication is 
characterized by the temporally regulated expression of genes characterized by early, intermediate 
and late gene expression. Genus-common, non-structural protein 100K is encoded by late region 
L6 of BAdV-3. The objective of the present study was to characterize the BAdV-3 100K protein 
and identify cellular and viral proteins interacting with 100K. 
 Although BAdV-3 100K encoded as 850 amino acid polypeptide (Reddy et al., 1998), rabbit 
antisera raised against peptides representing N-terminus or C-terminus recognized a protein of 130 
kDa at 12-24 hrs post infection, and proteins of 130 kDa, 100 kDa, 95 kDa and 15 kDa at 36-48 
hrs post infection. The 100K appeared to be localized to the nucleus and cytoplasm of BAdV-3 
infected cells. In contrast, 100K localized predominantly to cytoplasm of transfected cells.  
However, BAdV-3 infection of cells transfected with 100K-EYFP expressing plasmid detected 
fluorescent protein in nucleus of the cells suggesting that another viral protein may be required for 
the nuclear localization of 100K.  
Using yeast two-hybrid and GST pull-down assays, 100K protein was shown to interact 
with BAdV-3 33K protein. These results were validated using bimolecular fluorescence 
complementation (BiFC) assay. Although, 100K protein interacts with 33K protein, co-expression 
of both proteins in transfected cells did not alter the cytoplasmic localization of 100K. Using GST-
pull down assay and BiFC assay, 33K interacting region of 100K was localized to a stretch of 13 
amino acids (624-637). Repeated attempts were not successful in rescuing a recombinant BAdV-
3 expressing mutant 100K (containing deletion of amino acids 624-637). 
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 The interaction of cellular protein(s) with 100K was determined by mass spectrometric 
analysis of immunoprecipitated 100K. Mass spectrometry of immunoprecipitate obtained by 
immunoprecipitating 100K protein from BAdV-3 infected cells harvested at 48 hrs post infection 
identified six proteins including dynein light chain (DYNLT)1. The initial identified interaction of 
100K with DYNLT1 was confirmed by the yeast two-hybrid assay, co-immunoprecipitation assay 
and BiFC assays. Furthermore, DYNLT1 interacting domain of 100K protein of BAdV-3 was 
found to be located between 499-587 amino acids. Co-expression of BAdV-3 100K-EY fusion 
protein with myc epitope tagged DYNLT1 protein did not alter the localization of 100K-EY fusion 
protein. 
 The investigation into the differences in the subcellular localization of the 100K protein in 
the transfected and infected cells lead to identification of the cleavage by adenoviral protease. 
Subsequent analysis suggested that BAdV-3 protease cleaves 100K at two identified potential 
protease cleavage sites (amino acid 740-745 and 781-786) in transfected or BAdV-3 infected cells. 
Although protease encoded by human adenovirus (HAdV)-5 or porcine adenovirus (PAdV)-3 also 
cleaved BAdV-3 100K at potential identified protease cleavage sites, no such cleavage of 100K 
encoded by HAdV-5 or PAdV-3 could be detected in cells expressing virus specific protease. 
Successful isolation of recombinant BAdV-3 expressing mutant protease (substitution of alanine 
for glycine in potential protease cleavage site) suggested that cleavage of BAdV-3 100K by viral 
protease is not essential for viral replication. However, further analysis observed less virus in the 
supernatant of cells infected with mutant BAdV-3 compared to WT BAdV-3 suggesting a possible 
role for cleaved C-terminal fagment in lysis of infected cells. 
 Co-expression of BAdV-100K with other late viral proteins suggested that the 100K-EYFP 
fusion protein localized to the nucleus in cells co-expressing BAdV-3 protease-DsRed fusion 
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protein. Interestingly, only C-terminal cleaved fragment of 100K localizes to the nucleus in BAdV-
3 protease expressing cells. Further analysis suggested that C-terminal fragment localizing to the 
nucleus contains a bipartite nuclear localization signal, which is recognized by importin α3. Our 
results suggest that the N-terminal part of 100K may be retained in the cytoplasm by interaction 
with Tctex1 (DYNLT1). Our study provides for the first time a plasmid co-transfection system for 
the study of the protease cleavage of viral proteins. Moreover, this is the first report of cleavage of 
any non-structural viral proteins by adenoviral protease in infected cells. 
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1.0 LITERATURE REVIEW 
1.1 Adenoviruses 
Adenoviruses are non-enveloped, icosahedral shaped viruses, with linear double stranded 
DNA genome which infect wide range of vertebrates and leading to mostly non-clinical infections 
(Chiocca et al., 1996). The severity of the infection depends on the immunity of each individual 
host. Adenovirus infections are species specific and hence named after the host. Canine 
adenovirus-1 and -2 (Decaro et al., 2008), duck adenovirus-1 (Brash et al., 2009), fowl adenovirus-
4 (Adair et al., 2008) and turkey adenovirus-3 (Pitcovski et al., 1998) are some of the economically 
important adenoviruses of animals. Adenoviruses served as an important experimental system in 
the study of the cellular mechanisms of splicing and apoptosis (Chow et al., 1977; White, 1996). 
Recently, there has been a great interest in the use of adenoviruses as the vectors for gene delivery 
and for oncotherapy (Toth and Wold, 2010; Wong et al., 2013). 
1.1.1 Adenovirus taxonomy 
 Adenoviruses are classified under the family Adenoviridae, with unassigned order. 
Currently, family Adenoviridae is subdivided into five genera namely, Mastadenovirus (isolated 
from mammals), Aviadenovirus (isolated from birds), Atadenovirus (high Adenine + Thymine 
genome content), Siadenovirus (isolated from birds and reptiles) and Ichtadenovirus (contains a 
single species virus) (International Committee on Taxonomy of Viruses and King, 2012). The 
genome size of adenoviruses varies from 26 to 45 kbp of DNA molecule (Davison et al., 2003). 
There are sixteen genus common genes present in the genomes of adenoviruses which includes 
genes coding for DNA polymerase, terminal protein, DNA binding protein, 52K, IVa2, pIIIa, III, 
pVII, pX, pVI, hexon, protease, 100K, 33K, pVIII and fiber (Davison et al., 2003). With the advent 
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of next generation DNA sequencing technologies, classification of adenoviruses is based on DNA 
sequencing results. Typical adenoviral genomes can be divided into three distinct transcriptional 
units namely early, intermediate and late based on time of transcription after the onset of infection 
(Ferreira et al., 2005). 
 Mastadenovirus is the largest genera and has 25 species of adenoviruses of the mammals 
(International Committee on Taxonomy of Viruses and King, 2012). These viruses can infect 
humans, bovines, ovines, porcines, canines, equines, murines, bats, monkeys and shrews. Minor 
capsid protein pIX, core protein pV, with some proteins of E1, E3 and E4 regions are limited to 
Mastadenovirus genus only (Davison et al., 2003; Vellinga et al., 2005). Typical Mastadenovirus 
code for at least 40 proteins and human adenovirus C is the type species. Some viruses of this 
genus have been studied in great detail to elucidate the basic molecular host-pathogen interactions 
and also explored for their feasibility as viral vectors.  
 Aviadenovirus genus consists of 8 species of adenoviruses infecting various avian host 
species (International Committee on Taxonomy of Viruses and King, 2012). Based on genome 
sequence, Aviadenoviruses encode 47 to 54 open reading frames (Kajan et al., 2012). Five species 
were isolated from fowl (fowl adenovirus A-E), one from each falcon (falcon adenovirus A), 
turkey (turkey adenovirus B) and goose (goose adenovirus A) (International Committee on 
Taxonomy of Viruses and King, 2012). The turkey adenovirus 1 genome comprised of 45412 bp 
in length which makes it the longest genome of any known adenovirus (Kajan et al., 2010). The 
G+C % contents varies greatly among the members of this genus, turkey adenovirus 1 with 66.9 
% and goose adenovirus 4 with 44.7 % is the highest and lowest respectively (Kajan et al., 2012). 
Aviadenovirus contains some homologous and some unique genes in E1 and E4 regions as 
compared to Mastadenoviruses (Grgic et al., 2011). There is complete absence of homologues of 
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pIX, pV, E2 and E3 regions of genes as compared to other genera of adenoviruses (Davison et al., 
2003). Members of avian adenoviruses consists two fiber genes and fowl adenovirus A is a type 
species (Chiocca et al., 1996; International Committee on Taxonomy of Viruses and King, 2012). 
 Atadenovirus genus is named after the very high content of A+T in their genomes (Fields et 
al., 2007) and includes five species of adenoviruses (Davison et al., 2003; International Committee 
on Taxonomy of Viruses and King, 2012). Viruses of this genus include isolates from mammals 
(bovine adenovirus D, ovine adenovirus D, possum adenovirus A), a bird (duck adenovirus A) and 
a reptile (snake adenovirus A). Ovine adenovirus type 7 belongs to type specie ovine adenovirus 
D of Atadenovirus and does not targeted to liver and hence very promising for vector development 
(Bridgeman et al., 2009). Two genes p32K and RH are genus specific genes of atadenoviruses and 
present in E1 and E4 regions of the genome (Davison et al., 2003). 
 Siadenovirus genus currently consists of four species from an amphibian (frog adenovirus A 
– the type species) and birds (great tit adenovirus A, raptor adenovirus A, turkey adenovirus A) 
(International Committee on Taxonomy of Viruses and King, 2012). Viruses of this genus have 
the genomes of around 26 kbp, which represents the smallest adenoviral genomes known (Kovacs 
et al., 2010; Kovacs and Benko, 2011). Presence of sialidase gene homologue in the E1 region of 
these viruses gave them the name Siadenoviruses (Davison et al., 2003). There is complete absence 
of the E2 homologue of Mastadenoviruses in the Siadenovirus. 
 Ichtadenovirus is the fifth genus and the latest addition to the family Adenoviridae 
(International Committee on Taxonomy of Viruses and King, 2012). There is only one species 
sturgeon adenovirus A, which is also the type species and fish as host organism. The full length 
DNA sequencing of the white sturgeon adenovirus (WSAdV)-1 genome is yet to be achieved. 
Based on the partial DNA sequencing results of the WSAdV-1, the presence of two nucleotides 
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between the hexon gene and beginning of protease gene is different from other adenoviral genera 
(Kovacs et al., 2003). There was also the presence of two stop codons at the end of hexon genes 
as compared to only one in all other four recognized adenoviral genera (Kovacs et al., 2003). 
Phylogenetic analysis of the available DNA sequence also suggests the separate genus for 
WSAdV-1 (Benko et al., 2002). 
1.1.2 Human adenovirus 
 Human adenoviruses are among the most intensively studied adenoviruses since their 
isolation from human adenoid tissues (Rowe et al., 1953). Generally, adenovirus does not produce 
clinical infections in adult healthy individuals, but can cause serious complications in 
immunocompromised individuals, infants and elderly. The adenoviral infections of human are 
limited to respiratory, enteric, ocular, renal or hepatic organs (Arnberg. 2012). Currently, there is 
no therapeutic anti-adenoviral drug available for the treatment of adenoviral infections (San 
Martin, 2012). 
 There are currently seven species of human adenoviruses (A through G) have been classified 
under the Mastadenovirus genus consisting at least 57 different types (International Committee on 
Taxonomy of Viruses and King, 2012; Walsh et al., 2011). The grouping of human adenovirus (A 
to G) depends on the ability of virus to agglutinate the red blood cells of different animals (human, 
mokney or rat), ability to produce the tumors in the experimentally infected rats and transformation 
of cultured cells (Fields et al., 2007; Russell, 2009). The genome organization of a typical human 
adenovirus includes the presence of early genes (E1 through E4), intermediate genes (pIX, IVa2) 
and late genes (Russell, 2009). Recently, human adenovirus isolates are grouped based on the 
DNA sequence of variable region of hexon, fiber or penton and other genes (Robinson et al., 2011; 
Walsh et al., 2011; Matsushima et al., 2012).  
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1.1.2.1 Virus life cycle 
 As viruses are obligate intracellular microorganisms, the production of the progeny virus can 
only takes place in the living cells. For entry into a susceptible cell, a virus needs to attach to the 
cell surface receptor using viral protein(s). Attachment is very specific process and consists of 
primary (fiber knob) and secondary (penton base) receptors attachment with cellular receptors 
(CAR and integrins). These specific interactions lead to the endocytosis of adenoviral particle. The 
acidic pH of endosomal compartment and toxic nature of the viral capsid proteins lead to release 
of the viral particle into the cytoplasm.  
 The viral particle is transported to the nucleus using microtubules and viral DNA along with 
some viral proteins enters the nucleus via importin receptors (Greber et al., 1997). Viral DNA 
associates with the histone at the active transcription sites leading to the early gene expression. 
Early adenoviral proteins block the apoptosis and prepare the cell for viral DNA replication 
(White, 2001; Giberson et al., 2012). Once the early proteins are synthesized, the viral DNA 
replication commences. DNA replication can be type I, which begins at both the ends of linear 
double stranded viral DNA through inverted terminal repeats (ITR) and type II, starts from 
panhandle on circular molecule from ITR (Lechner and Kelly, 1977). 
 Viral late gene expression is controlled by the activation of major late promoter (MLP). The 
MLP transcription unit is of around 29 kb and organized into five families (L1 to L5) of transcripts, 
based on the usage of poly (A) site (Berk, 2007). Use of different splice site lead to the transcription 
of around 20 species of late mRNA encoding the structural and non-structural viral proteins (Fraser 
et al., 1982). 
 The process of adenoviral assembly begins in the nucleus after the completion of the DNA 
replication and late gene translation. The non-structural proteins (33K, 52K and 100K) act as 
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chaperons or scaffolding proteins and help in the formation of capsid. Adenoviral proteins IVa2 
and L1-52K proteins bind with terminal viral DNA packagaging sequences followed by insertion 
of viral DNA in to capsid (Ostapchuk and Hearing, 2005). The adenoviral protease cleaves at least 
six structural proteins before immature virions become mature virion. Mature virus release can be 
facilitated by the combination of action of some of the viral and host factors. 
1.1.2.2 Structural proteins 
 Structural proteins are the components of the mature adenovirus and can be grouped into 
major capsid proteins (hexon, penton, fiber), minor capsid proteins (IIIa, pVI, pVIII, pIX) and core 
proteins (pV, pVII, Mu, terminal protein, IVa2, protease) (Russell, 2009). Recently, detailed 
structures of human adenovirus (HAdV)-5 have been obtained employing X-ray diffraction 
analysis and cryo-electron microscopy at 3.5 angstrom (Å) and 3.6 Å resolutions respectively (Liu 
et al., 2010; Reddy et al., 2010). The major functional details of each of the adenoviral structural 
proteins are given in the Table 1.2. 
1.1.2.3 Non-structural proteins 
 The proteins that are encoded by the adenovirus and not part of the mature virion are known 
as non-structural proteins. Viral products encoded by E1A, E1B, E2, E3 and E4 group of early 
proteins along with late non-structural proteins forms the major groups of non-structural proteins 
of adenovirus. Adenovirus MLP controls the expression of five families of the late genes, which 
includes all structural proteins (except IVa2 and pIX) and many non-structural proteins (52/55K, 
100K, 33K and 22K) (Berk, 2007). Details of the important non-structural proteins are provided 
in the Table 1.3. 
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1.1.3 Human adenovirus 100K protein 
 L4 family of late mRNA synthesizes the 100K protein, which is 805 and 807 amino acids in 
length in HAdV-2 and HAdV-5 respectively. The role of 100K protein in trimerization of hexon 
protein was suggested using temperature sensitive 100K mutant HAdV-5 cell lysate incubated with 
immunoprecipitated wild type 100K protein (Oosterom-Dragon and Ginsberg, 1981). Further, role 
of 100K protein as chaperone in the proper folding of the hexon protein was elucidated by co-
expression of both the proteins in Sf9, an insect cell line (Hong et al., 2005). 100K protein of the 
HAdV-2 was found be phosphorylated mainly at serine residues in infected cells as determined by 
labeling experiments (Axelrod, 1978). Hexon trimerization was also assisted by 100K protein in 
HAdV-2 as suggested by immunoprecipation with monoclonal anti-100K antibody coupled with 
pulse chase experiments (Cepko and Sharp, 1982). 
 Role of 100K protein in the translation of late adenoviral mRNA with tripartite leader (TPL) 
has been studied in some detail. Initiation of translation of late and intermediate genes of 
adenovirus were impaired as identified by polyribosome analysis of temperature sensitive mutant 
(Hayes et al., 1990). Isolation of revertant virus restored the defective functions which was 
suggestive of the role of 100K protein in translation of TPL containing RNA (Hayes et al., 1990). 
Reports suggested that 100K protein of HAdV-2 interact with the TPL containing mRNA and 
initiates the translation of late viral mRNA using special initiation mechanism known as ribosomal 
shunting (Xi et al., 2004). Phosphorylation at two tyrosine residues 365 and 682 of HAdV-2 100K 
are essential for this function (Xi et al., 2005). 100K protein interaction with the eukaryotic 
initiation factor (eIF)4G initiation complex and TPL was found to be important for the process of 
ribosomal shunting as identified by in vivo RNA binding and polysomes assays (Xi et al., 2004). 
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Table 1.1 Role of major adenoviral factors in viral life cycle 
Viral factor Role in viral life cycle  
fiber knob 
protein 
Attachment with coxsackie and adenovirus receptor (CAR) in HAdV 
species A, C, D, E and F (Cupelli and Stehle, 2011; Arnberg. 2012), CD46 
in species B HAdV (Gaggar et al., 2003; Marttila et al., 2005), CD80 and 
CD86 molecules in species B HAdV (Short et al., 2006), sialic acid in 
HAdV-37 (Nilsson et al., 2011). 
Penton base 
Integrins αv β3 and αv β5 interacts with RGD motif of penton base 
(Wickham et al., 1993) leading to activation of phosphoinositide-3-OH 
kinase (PI3K) (Li et al., 1998b), p130CAS (crk-associated substrate)(Li et 
al., 2000), GTP binding proteins Rac and CDC42 (Li et al., 1998a) and 
endocytosis of the virus particle and internalization (Cupelli and Stehle, 
2011). 
pVI 
Breaking of endosomal compartment and release of viral particle in 
cytosol (Wiethoff et al., 2005; Smith et al., 2010; Scherer and Vallee, 
2011). 
Hexon protein 
Interacts with dynein intermediate chain 2 C and dynein light intermediate 
chain 1 result in the viral capsid transport (Bremner et al., 2009). 
pVII 
Binds tightly with the adenoviral DNA and get imported to the nucleus of 
infected cells (Xue et al., 2005). 
pVI 
Displaces death domain associated protein (Daxx) from interacting with 
the adenoviral promoter E1A to commence the transcription of early genes 
(Schreiner et al., 2012). Promote the nuclear import of hexon protein 
(Wodrich et al., 2003). 
viral DNA 
Binds with the acetylated histon 3.3 suggestive of active transcription sites 
similar to cellular genes (Komatsu et al., 2011). 
E1A protein 
Conserved regions CR1 or CR2 can drive the infected cell from G0 to S 
phase which creates the favorable condition for the replication of 
adenoviral DNA (Berk, 2005). 
E1A protein CR2 binds with the retinoblastoma protein and related 
proteins (p107 and p130) which repress the transcription factor E2F 
responsible for transcriptional activation of genes for progression in to S 
phase (Ghosh and Harter, 2003) 
VA RNAI 
Block the dsRNA protein kinase activation and hence allow the cell to 
perform the normal level of protein synthesis during the late stages of 
adenoviral infection (Ghadge et al., 1994). 
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Table 1.1 cont. 
Viral factor Role in viral life cycle  
E4orf1 and 
E4orf4 
Activate the mammalian target of rapamycin (mTOR) pathway resulting in 
S-phase entry of infected cell by triggering PI3 kinase and p70S6K 
phosphorylation respectively (O'Shea et al., 2005). 
Inverted terminal 
repeats (ITR) 
DNA replication commences from ITR (Lechner and Kelly, 1977). 
Preterminal 
protein (pTP) and 
DNA polymerase 
These proteins interact with the 8-17 bases of ITR viral DNA as 
heterodimer, which is essential for the replication of viral DNA 
(Temperley and Hay, 1992; Webster et al., 1997). 
Viral protein pTP act as the primer for DNA replication for the initiation 
of replication (de Jong and van der Vliet, 1999). 
DNA binding 
protein (DBP) 
Enhances the ability of the viral DNA polymerase to commence the 
replication of viral DNA (van Breukelen et al., 2003) 
E1B-55K protein 
Bind with the cellular pro-apoptotic activator protein p53 and represses the 
transcriptional activation of apoptotic genes (Levine. 1997; White, 2001). 
E4orf6 
Interact with p73, a homologue of p53 and prevents the apoptosis of 
infected cell (Steegenga et al., 1999). 
E1B-19K 
Interact with proapoptotic mitochondrial BCL-2 homologous 
antagonist/killer 1 protein and prevent apoptosis (Lomonosova et al., 
2005). 
Major late 
promoter 
Viral proteins IVa2, pIX and 33K stimulate the MLP activation leading to 
expression of late genes (Lutz et al., 1997; Iftode and Flint, 2004; Ali et 
al., 2007). 
E1B-55K and 
E4orf4 
Selectively promote the export of viral late mRNA and blocks the cellular 
mRNA export from the nucleus (Blanchette et al., 2008). 
100K protein 
A multifunctional protein with integral role in ribosomal shunting, 
translation of tripartite leader (TPL) containing late viral mRNA and 
hexon protein synthesis (Xi et al., 2004; Xi et al., 2005; Koyuncu et al., 
2012). Binds with translation initiation factor eIF4G and TPL to promote 
the translation of late viral genes (Xi et al., 2004). Act as chaperon in the 
translation, folding and trimerization of hexon protein in the cytoplasm 
(Hong et al., 2005). 
IVa2  
Bind with 22K and 52K proteins and help in viral DNA packaging in to 
the capsid (Ostapchuk and Hearing, 2005; Ewing et al., 2007). 
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Table 1.1 cont. 
 
Viral protein Role in viral life cycle  
33K protein 
A phosphoprotein act as viral splicing factor for IIIa mRNA and 
transcription factor for MLP (Tormanen et al., 2006; Ali et al., 2007; 
Tormanen Persson et al., 2012). Involved in control of late gene 
expression and viral DNA packaging in infected cells (Wu et al., 2013). 
µ protein 
Perform conformational change to adenoviral DNA and assist in the 
packaging of the genome in to the capsid (Russell, 2009). 
Adenoviral 
protease 
Cleaves six viral proteins (pIIIa, pVI, pVIII, pVII, pTP and pµ) and help in 
proteolytic maturation of virion (San Martin, 2012). 
Pentone 
Pentamerize in the cytoplasm and get imported to the nucleus for the 
capsid formation (Liu et al., 2011). 
E3-11.6K 
Responsible for the cell death and release of the progeny viruses 
(Tollefson et al., 1996). 
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Table 1.2 Role of major and minor adenoviral structural proteins in the viral life cycle 
Viral protein Role in viral life cycle  
Hexon 
Major capsid protein, which forms trimers and arranged as 12 molecules 
on each of 20 facets of the icosahedron (San Martin, 2012). 
Penton base 
Associates with four hexon trimers to form the icosahedral asymmetric 
unit of capsid (San Martin, 2012). 
Fiber 
The fiber tail interacts with the penton pentamer and the knob interacts 
with the CAR receptor and these interactions are essential for the 
attachment of the virus with the cellular surface (Cao et al., 2012). 
Polypeptide IIIa 
Consists of group of six-glue domain, hexon-binding domain, pVIII-
binding domain and core-proximal domain (Liu et al., 2010). 
pVI 
Located on the inner side of the capsid under the hexon and around 360 
copies per virion (Liu et al., 2010). 
pVIII  
Each molecule interacts with the four molecules of hexon in the capsid and 
hence also known as the hexon associated protein (Liu et al., 2010). 
pIX 
Present as trimer on facet at four positions, which act as cementing protein 
for the group of nine hexons (Reddy et al., 2010) 
pV 
Located inside the capsid beneath the major capsid proteins in mature 
virion. 
pVII 
Associated with the viral DNA as the part of nucleoprotein protecting viral 
nucleic acid from the action of cellular MRN (Chen et al., 2007; Karen 
and Hearing, 2011). 
Mu 
About 100 copies per virus particle attached with the viral DNA (Russell, 
2009). 
Terminal protein 
Serve as the primer for viral DNA replication (Pronk and van der Vliet, 
1993). 
IVa2 
Interact with the adenoviral packaging DNA sequence (Ostapchuk et al., 
2005; Ostapchuk et al., 2011). 
Protease 
Cleaves viral proteins at consensus motif [M/I/L]-x-G-x-G or [M/I/L]-x-
G-G-x and important for the maturation of virion (Webster et al., 1989; 
Diouri et al., 1996). 
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Table 1.3 Role of important non-structural proteins in the adenovirus life cycle 
Viral protein Role in viral life cycle  
E1A region 
 289R 
 243R 
 217R 
 171R 
 55R 
Produced before viral DNA replication and act as the hub and essential 
for the productive viral infection (Jones and Shenk, 1979; Stephens and 
Harlow, 1987; Ulfendahl et al., 1987; Pelka et al., 2008). 
E1B region 
 55K  
 19K 
 156R 
 93R 
 84R 
E1B-55K and 19K proteins have important roles in the viral replication 
and transformation of cells in culture (Takayesu et al., 1994; Sieber and 
Dobner, 2007). 
E2 region  
DNA polymerase 
Plays important role in viral DNA replication by interacting with the pTP 
for initiation (Liu et al., 2000). 
E3 region 
 11.6K/ADP 
 gp19K 
 10.4K 
 14.5K 
 6.7K 
 14.7K 
 12.5K 
The E3-10.4K and 14.5K helps in immune evasion (Hilgendorf et al., 
2003; Lu et al., 2009; Sharma and Andersson, 2009). E3-gp19K 
restricting the expression of major histocompatibility complex (MHC) 
class I molecules on the surface of the HAdV-2 infected cell (Fu et al., 
2011). The 11.6K/ adenovirus death protein (ADP) responsible for the 
cell lysis and release of mature viral progeny (Tollefson et al., 1996). 
Protein 14.7K inhibit tumor necrosis factor (TNF) mediated cell lysis in 
the adenovirus-infected cells (Krajcsi et al., 1996). Protein 6.7K with 
10.4K and 14.5K displaces the TNF-related apoptosis-inducing ligand 
receptor-2 from the adenovirus infected cell surface and prevent the 
apoptosis (Lichtenstein et al., 2004). 
E4 region 
 E4orf1 
 E4orf2 
 E4orf3 
 E4orf4 
 E4orf3/4 
 E4orf6 
 E4orf6/7 
E4 region codes for seven proteins (Bridge and Ketner, 1989).E4orf4 
responsible for induction of apoptosis transfected cells (Brestovitsky et 
al., 2011). E4orf1 protein was found to interact with the PI3K pathway 
leading to mTOR activation (O'Shea et al., 2005). E4orf6 is 294 amino 
acid protein with a role in degradation of p53 (Nevels et al., 2000). 
33K protein 
A phosphoprotein act as viral splicing factor for IIIa mRNA and 
transcription factor for MLP (Tormanen et al., 2006; Ali et al., 2007; 
Tormanen Persson et al., 2012). Involved in control of late gene 
expression and viral DNA packaging in infected cells (Wu et al., 2013). 
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Table 1.3 cont.  
Viral protein Role in viral life cycle  
100K protein 
A multifunctional protein with integral role in ribosomal shunting, 
translation of tripartite leader (TPL) containing late viral mRNA and 
hexon protein synthesis (Xi et al., 2004; Xi et al., 2005; Koyuncu et al., 
2012). Binds with translation initiation factor eIF4G and TPL to promote 
the translation of late viral genes (Xi et al., 2004). Act as chaperon in the 
translation, folding and trimerization of hexon protein in the cytoplasm 
(Hong et al., 2005). 
52K protein Serotype specific viral DNA packaging (Wohl and Hearing, 2008). 
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 The Mnk1 (MAP kinase-interacting serine/threonine-protein kinase 1) protein 
phosphorylates the eukaryotic initiation factor eIF4E, which in turn initiates the translation via 
cap-dependent scanning mechanism (Walsh and Mohr, 2011). The cap-dependent translation of 
cellular mRNA is inhibited by the competitive removal of Mnk1 protein from eIF4G (translation 
initiation factor) by the 100K protein (Cuesta et al., 2000). Inerestingly, binding of the 100K 
protein to RNA was not essential for the removal of the Mnk1 from the translation initiation 
complex (Cuesta et al., 2004).  
 The nuclear and cytoplasmic fractions of HAdV-2 infected HeLa cells were found to contain 
the 100K protein (Gambke and Deppert, 1981). Nuclear and cytoplasmic localization of Flag 
tagged 100K protein of HAdV-2 was reported in the transfected and infected HeLa cells (Gambke 
and Deppert, 1981; Cuesta et al., 2004). Presence of a functional Rev-like nuclear export signal 
(NES) was identified in the 100K protein (383LCNLVSYLGI392) of HAdV-2 and confirmed by 
retention of the NES deleted 100K protein in the nucleus of the transfected HeLa cells (Cuesta et 
al., 2004). Interestingly, transfection of C-terminally HA tagged 100K gene alone or with C-
terminally myc tagged hexon gene of HAdV-5 was localized to the cytoplasm of transfected cells 
(Wodrich et al., 2003). Glycine-alanine-arginine (GAR) repeats (Koyuncu and Dobner, 2009) but 
not arginine-glycine-glycine (RGG) repeats (Cuesta et al., 2004) at the C-terminus of 100K protein 
were found responsible for the nuclear localization of the protein in HAdV-5 infected cells. 
Interestingly, the mutated 100K containing mutant NES was localized to the cytoplasm of mutant 
HAdV-5 (Koyuncu et al., 2012). 
 The RGG or GAR boxes located at the C-terminal of HAdV-5 100K protein are methylated 
posttranslationally at arginine residues by the action of protein arginine methyltransferase 1 
(PRMT1) and are suggested to mediate the interaction of 100K with hexon protein and TPL 
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sequence of the viral mRNA (Koyuncu and Dobner, 2009). However, amino acids 215-420 of 
100K protein of HAdV-5 interact with Hexon in GST pull-down assay (Koyuncu et al., 2012). 
Interestingly, the wild-type GST-100 fusion protein failed to interact with the hexon protein from 
the HAdV-5 infected cell lysate (Koyuncu et al., 2012). 
1.1.4 Human adenovirus protease 
 Adenovirus protease is also referred to as adenovirus endoprotease, adenovirus 
endopeptidase, adenovirus proteinase and adenain in the literature. The role of the adenoviral 
protease in precursor polypeptide processing was suggested by the experiments with the 
temperature sensitive adenoviral mutants, which failed to cleave the six structural viral proteins 
(Weber, 1976). A highly conserved protease about 200 amino acids is encoded by all the 
adenoviruses studied to date (Tong, 2002; Davison et al., 2003). The protease expression was 
observed higher at the late phase of HAdV-2 infection and equally distributed in the cytoplamic 
and the nuclear fraction of HeLa cells (Webster et al., 1994). The cysteine protease inhibitors l(p-
chloromercuribenzoate, iodoacetic acid, N-ethylmaleimide and 4,4'-dithiodipyridine) inhibited the 
bacterially expressed recombinant adenoviral protease activity to cleave HAdV-2 pVII protein 
(Tihanyi et al., 1993).  However, based on the 2.6 Å resolution structure of HAdV-2 proteinase 
complex with c-terminal 11 amino acids of pVI, and the catalytic triad of H54, E71 and C122 was 
identified, which place it in new fifth class of cysteine proteases (Ding et al., 1996).  
 The pVIc (11 amino acids) and HAdV-2 DNA were biochemically identified as cofactors 
for the optimum protease activity (Mangel et al., 1996; Mangel et al., 1997). The presence of C-
terminal fragment of adenovirus pVI ptotein or HAdV-2 DNA was found to increase protease 
efficiency by 355 and 6072 times, respectively as compared to protease alone (Mangel et al., 1996). 
For the production of infectious progeny virus, the adenoviral protease specificly cleaves at least 
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six major proteins at 3200 sites in total (Mangel et al., 2003). A crystal structure of adenoviral 
protease with a cofactor identified four large areas with positive charge which were suggested to 
interact with the viral DNA (Ding et al., 1996). In addition to the consensus protease cleavage sites 
[M/I/L]-x-G-x-G and [M/I/L]-x-G-G-x the more relaxed site specificity [M/I/L/Q]-x-G-x-G was 
also observed for the terminal protein of HAdV-4 (Webster et al., 1997). Sequence anaylsis of the 
viral protease substrate proteins suggest the absence of cysteine residues at eight amino acids on 
either side of the scissile bond (Ruzindana-Umunyana et al., 2002). As no anti-adenoviral drugs 
are available for clinical use, adenoviral protease provides the ideal target for developing 
therapeutic intervention (Weber, 2003).  
 The HAdV-2 proteins 100K, pV and hexon were found to be cleaved by adenoviral protease 
in an in vitro assay (Ruzindana-Umunyana et al., 2002) The in vitro cleavage of 100K protein by 
HAdV-2 protease was suggested to be physiologically irrelevant based on 100K protein function 
and activation of protease (Ruzindana-Umunyana et al., 2002). 
1.1.4 Bovine adenovirus 
 Bovine adenovirus (BAdV) was first isolated in 1959 from respiratory secretion of a cow 
(Klein et al., 1959). Currently, fourteen serotypes of bovine adenovirus have been detected from 
the cattle samples (Lehmkuhl and Hobbs, 2008; Sibley et al., 2011) from the diseased cattle 
(Horner et al., 1989; Graham et al., 2005), healthy cattle (Mattson et al., 1988) or from the 
environment samples (Sibley et al., 2011). 
1.1.4.1 Classification 
 Currently the BAdVs are classified under two genera Mastadenovirus (BAdV-1, -2, -3, -9, -
10, -WIa, -WIb, -WIc) or the Atadenovirus (BAdV-4, -5, -6, -7, -8, -Rus) (Table 1.4) (Lehmkuhl 
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and Hobbs, 2008; Sibley et al., 2011). Genome length, nucleotide content and restriction enzyme 
analysis pattern are the criteria for placement of the BAdVs into two genera (Benko et al., 1988). 
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Table 1.4 Classification of bovine adenoviruses 
Mastadenovirus  
   Bovine adenovirus A BAdV-1, -WIa, -WIb 
   Bovine adenovirus B BAdV-3 
   Bovine adenovirus C BAdV-10, -WIc 
   Ovine adenovirus A BAdV-2 
   Human adenovirus C BAdV-9 
Atadenovirus  
   Bovine adenovirus D BAdV-4, -5, -8, -Rus 
   Bovine adenovirus Ea BAdV-6 
   Bovine adenovirus Fa BAdV-7 
a International Committee on Taxonomy of Viruses unapproved species of bovine adenovirus 
(Lehmkuhl and Hobbs, 2008; Sibley et al., 2011). 
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1.1.4.2 Bovine adenovirus type 3 
 Bovine adenovirus type 3 (WBR I strain) was first isolated in 1965 from the eye swab of a 
healthy cow (Darbyshire et al., 1965a). BAdV-3 did produce the clinical disease in colostrum 
deprived calves by intranasal inoculation (Darbyshire et al., 1965b). In 2011, the BAdV-3 was 
isolated from the sick calves in China (Zhu et al., 2011). Tumor development was observed in 
hamster pups following the inoculation of BAdV-3 by various parental routes (Darbyshire. 1966). 
BAdV-3 uses the sialic acid receptor for the cellular entry (Li et al., 2009). 
1.1.4.2.1 Genome organization 
 The BAdV-3 contains a double stranded DNA genome of 34,446 nucleotides with 54% G+C 
content (Reddy et al., 1998). The genome size of BAdV-3 is similar to HAdV-2 (35,937 bp, 
AC_000007.1), HAdV-5 (35,938 bp, AC_000008.1), HAdV-7 (35,514 bp, AC_000018.1) and 
HAdV-35 (34,794 bp, AC_000019.1) (Benson et al., 2011). Like any Mastadenovirus, the genome 
of BAdV-3 is organizied into early (E1 [E1A, E1B], E2 [E2A, E2B], E3 and E4), intermediate 
(IVa2, pIX), and late (L1 to L7) regions (Reddy et al., 1998). The relative position of different 
regions on the genome resembles to that of the prototype Mastadenovirus HAdV-5 except the 
organization of late region (Reddy et al., 1998; Davison et al., 2003). In BAdV-3, there are seven 
families of late genes are present as opposed to five families of late genes in HAdV-5. 
 Moreover, the ITR of BAdV-3 is 195 nucleotides, which is longer than the ITR HAdV-2 
(102 bp) and HAdV-5 (103 bp) (Reddy et al., 1998; Davison et al., 2003). 
1.1.4.2.2 Structural proteins 
Major Proteins 
 The L1 region encoded penton protein is 482 amino acids long and shares identity of 44% 
to 64% with penton proteins of other adenoviruses (Reddy et al., 1998). The integrin interacting 
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motifs arginine-glycine-aspartic acid (RGD) and LDV present in penton of other adenoviruses are 
absent in BAdV-3 penton protein (Komoriya et al., 1991; Wickham et al., 1993; Reddy et al., 
1998). Absence of the RGD motif in the penton of BAdV-3 suggests that integrin(s) may not be 
used as receptor for virus entry (Reddy et al., 1998). The L5 region encoding hexon protein of 
BAdV-3 is 910 amino acids long and shares sequence identity with hexon proteins of other 
adenoviruses (54.3% to 70.8%) (Reddy et al., 1998). The hexon protein monomers can be detected 
as 98 kDa proteins in the mature virions and empty capsids of BAdV-3 (Kulshreshtha et al., 2004). 
The L7 region encoding fiber protein is 976 amino acids long and shows identity of 17% to 26% 
with fiber proteins of other adenoviruses (Reddy et al., 1998). Three additional leader sequences 
present at the 5’ end of HAdV-2 fiber mRNA are missing at 5’ end of BAdV-3 fiber mRNA (Chow 
et al., 1977; Reddy et al., 1998). Like other Mastadenoviruses, BAdV-3 fiber protein can be 
devided into knob, shaft and tail regions (Reddy et al., 1998). The knob region is involved in the 
initial interaction of BAdV-3 with the cellular receptor (Bangari et al., 2005). The shaft region of 
BAdV-3 fiber is long and bent (Ruigrok et al., 1994). The tail region of BAdV-3 contains the 
conserved FNLVYPYKA motif and is suggested to play an important role in the interaction of 
fiber with the penton protein (Caillet-Boudin. 1989; Reddy et al., 1998). The BAdV-3 fiber protein 
is detected as 102 kDa in infected cells and contains a nuclear localization signal (the amino acids 
14 to 20), which appears to be important for the viral replication in Madin-Darby bovine kidney 
(MDBK) cells (Wu et al., 2004). Replacement of the knob region of BAdV-3 with the knob region 
of HAdV-5 fiber has been helpful in altering the tropism of BAdV-3(Wu and Tikoo, 2004). 
Minor Capsid Proteins 
 The L1 region encoded IIIa protein is 568 amino acids long and shows sequence identity of 
25.2% to 57.2% with IIIa proteins of other adenoviruses (Reddy et al., 1998). Similar to the HAdV-
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5 IIIa protein, the putative protease cleavage site is present in the the C-terminus of BAdV-3 IIIa 
(Reddy et al., 1998; San Martin, 2012). 
 The L4 region encoded VI protein is 263 amino acids long and shows identity of 15% to 
38% with VI proteins of other adenoviruses (Reddy et al., 1998; Berk, 2007). The C-terminus of 
BAdV-3 VI protein is homologous to the C-terminus of HAdV-2 VI protein, which acts as the 
cofactor for the adenoviral protease (Reddy et al., 1998; Honkavuori et al., 2004). Similar to other 
other adenovirus VI, the two putative adenoviral protease cleavage sites are also present in the 
BAdV-3 pVI protein (Reddy et al., 1998).  
 The L6 encoded VIII protein is 216 amino acids long and shares 19% to 56.5% sequence 
identity with VIII proteins of other adenoviruses (Reddy et al., 1998). BAdV-3 pVIII possesses 
two putative adenoviral protease cleavage sites at amino acid position 108 and 143 (Reddy et al., 
1998). Interestingly, only two of the three reported protease cleavage sites in HAdV-5 pVIII 
protein (San Martin, 2012) are present in BAdV-3 VII. 
 The intermediate region encoded pIX protein is 125 amino acids long and shares 16.5% to 
27.2% with pIX proteins of other adenoviruses (Reddy et al., 1998; Reddy et al., 1999a). The pIX 
protein is detected as 14 kDa protein in purified virions and in virus infected cells (Zakhartchouk 
et al., 2004) The C-terminus of pIX is exposed on the surface of the virion, which is utilized to 
incorporate heterologous proteins (Zakhartchouk et al., 2004). 
Core proteins 
 The L1 region encoding the VII protein is 171 amino acid long and shares 29.7% to 53.2% 
identity with VII proteins of other adenoviruses (Reddy et al., 1998). The BAdV-3 VII protein 
contains a mitochondrial localization signal (amino acid 1-54), localizes to mitochondria, and 
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modulates ATP synthesis, mitochondrial Ca2+ and mitochondrial membrane potential (Anand, 
2011).  
 The L2 region encoded V protein is 410 amino acids and shares 28.3% to 40.9% identity 
with V proteins of other adenoviruses (Reddy et al., 1998). The BAdV-3 V is detected at 36 hrs 
post infection as a 56 kDa protein in infected cells (Kulshreshtha and Tikoo, 2008). 
 The L3 region encoded X protein is 80 amino acids long (Anderson et al., 1989; Reddy et 
al., 1998) and contains two putative protease cleavage sites (Reddy et al., 1998). The L5 region 
encoded protease is 204 amino acid long and shares 30.3% to 65.7% identity with proteases of 
other adenoviruses (Reddy et al., 1998; Weber, 2007). 
 The E2B region encoded terminal protein (TP) is 649 amino acids long and has shares 24% 
to 59.9% sequence identity with TP of other adenoviruses (Reddy et al., 1998).  
 The E2B encoded IVa2 protein is 376 amino acids long and shares 29% to 69% identity with 
IVa2 proteins of other adenoviruses (Reddy et al., 1998). 
1.1.4.2.3 Non-structural proteins 
 E1 region: The E1 region expressed E1A is located between map units 0.8-10.5 and produces 
proteins of 211, 115 and 100 amino acids from alternatively spliced mRNAs. The E1A proteins 
are detected as 43, 57 and 65 kDa proteins at 12-48 hrs post infection in virus infected cells (Reddy 
et al., 1999b). The E1A protein (s) appear essential for replication of BAdV-3 (Zhou et al., 2001). 
The E1 expressed E1B region maps to 4.2-10.5 map units and produces proteins of 157 and 420 
amino acids from two overlapping mRNAs (Reddy et al., 1999). The E1B proteins are detected as 
19 kDa and 48 kDa proteins from 6-48 hrs post infection in virus infected cells (Reddy et al., 
1999b). While 19 kDa protein appears non-essential for BAdV-3 replication in fetal bovine retina 
cells, it appears essential for BAdV-3 replication in bovine fibroblast cells (Zhou et al., 2001). 
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Unlike HAdV-2, the E1A and E1B transcripts of BAdV-3 shares the common 3’ terminus (Berk 
and Sharp, 1978; Reddy et al., 1999a). Interestingly, a replication-competent BAdV-3 could be 
isolated by deleting the DNA sequence between left ITR and start of E1A region suggesting that 
ITR may act as promoter for E1A transcrion (Xing and Tikoo, 2006). 
 E3 region: The E3 region is located between map units 75 to 83 and produces proteins of 
284, 121, 86 and 82 amino acids from spliced mRNAs (Idamakanti et al., 1999). The E3 proteins 
are detected as glycoproteins of 48, 67 and 125 kDa and a protein of 14.7 kDa (Idamakanti et al., 
1999). The 67 and 125 kDa proteins appear to be post translationally modified forms of the 48 kDa 
protein (Idamakanti et al., 1999). The E3 proteins are not essential for replication of BAdV-3 in 
vitro (Zakhartchouk et al., 1998) or in vivo (Zakhartchouk et al., 1999). However, BAdV-3 E314.7 
kDa protein inhibits cytolysis of mouse cells by tumor necrosis factor (Zakhartchouk et al., 2001). 
 E4 region: The E4 region is located between map units 98.6 to 89.9 (Lee et al., 1998). The 
E4 region transcribes seven mRNAs which has the potential to encode unique proteins of 69, 143, 
143, 219 268 animo acids (Baxi et al., 1999). Mutational analysis of E4 region suggests that none 
of the individual proteins appear essential for replication of BAdV-3 (Baxi et al., 2001). 
 Late region: The L2 encoded 52K protein is 370 amino acids long (Paterson, 2010) and 
shares identity 21.4% to 61.6% with 52K protein of other adenoviruses (Reddy et al., 1998). The 
52K protein contains a bipartite nuclear localization signal and utilizes the nuclear import receptor 
importin α3 to localize in the nucleus of the transfected and virus infected cells (Paterson et al., 
2012). The 52K protein interacts with BAdV-3 encoded pVII and cellular protein NFkB-binding 
protein (Paterson, 2010). Co–expression of 52K and NFBP results in redistribution of NFBP from 
nucleolus to other parts of nucleus (Paterson, 2010).  
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 The L6 region encodes three proteins namely 33K, 22K and 100K. The 33K protein, a 
spliced form of 33K mRNA is 279 amino acids long. The 33 K protein is detected as two major 
proteins of 42 kDa and 22 kDa and five minor proteins of 39 KdA, 35 kDa, 29 kDa 25 KdA and 
19 kDa in virus infected cells (Kulshreshtha, 2009). The 33K localizes to nucleus and activates 
transcription from the major late promoter (Kulshreshtha, 2009). The highly conserved C-terminus 
of 33K appears to contain nuclear localization signals and major late preomoter DNA binding 
domains (Kulshreshtha, 2009). The 33K protein have been shown to interact with BAdV-3 protein 
pV and 100K (Kulshreshtha and Tikoo, 2008), and cellular protein bovine presenilin-1-associated 
protein (BoPSAP) (Kulshreshtha, 2009) using coimmunoprecipitation assay. 
 The 22K, an unspliced form of 33K mRNA is 274 amino acids in length. The 22K protein 
is detected as 41 kDa, 39 kDa and 37 kDa proteins in infected cells (Kulshreshtha, 2009). The 33K 
and 22K proteins share N-terminal 138 amino acids, which appear to be essential for replication 
of BAdV-3 including capsid assembly and/or capsid DNA encapsidation (Kulshreshtha et al., 
2004)  
 The L6 encoded 100K is 850 amino acids long and shares 27.6% to 52.1% identity with100K 
proteins of other adenoviruses (Reddy et al., 1998). Like other adenoviruses, the C-terminus of 
100K overlapps with 33K/22K proteins  
 The U exon protein (UXP) is 55 amino acids and is encoded by l strand of BAdV-3, which 
overlaps with the fiber gene and E3 region (Reddy et al., 1998; Ying et al., 2010). The UXP of 
HAdV-5 can be detected at 24 kDa from the infected cell lysate at 18 to 48 h post infection 
suggestive of mRNA splicing and localizes to the nucleus of infected A549 cells (Reddy et al., 
1998). 
 25 
1.2 Protein-protein interactions 
 Protein-protein interactions are the most important processes responsible for many 
viral/cellular functions at molecular level, which can involve two or more proteins (Sardiu and 
Washburn, 2011). Protein-protein interactions determine the final outcome of the host-pathogen 
relationship (Franzosa and Xia, 2011). Knowledge of the protein-protein interactions at molecular 
level can help in judging the disease outcome and formulating the strategy for treatment or 
prevention of the pathogenic infection of human and animals (Corcoran and Doyle, 2004; Li et al., 
2005; Miura and Holmes, 2009). Currently, the virus-host protein interactions are one of the major 
areas of virus research. 
1.2.1 Adenovirus-host protein interactions 
 As in other viruses, adenovirus proteins interact with the host proteins throughout the viral 
replication cycle and help in making favorable cellular environment for production of progeny 
virions. Study of the adenoviral-host protein interactions had lead to the understanding of cellular 
molecular processes including the discovery of Coxsackievirus and adenovirus receptor (CAR). 
Most of the host-pathogen interaction data available are the results of the studies on HAdV-2 and 
-5. Adenoviral proteins vary in terms of the number of cellular proteins they interact with, where 
some proteins have many cellular protein partners identified and some have few or none. Protein 
interactions of viral and cellular proteins, which have been discussed in previous sections, have 
been omitted to avoid repetition. 
1.2.1.1 Structural proteins 
 The protein-protein interactions between viral structural proteins and cellular proteins are 
listed in the Table 1.5. 
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1.2.1.2 Non-structural proteins 
 The protein-protein interactions between viral non-structural proteins and cellular proteins 
are listed in the Table 1.6. 
1.2.2 Adenoviral protein-protein interactions 
 The protein-protein interactions between viral proteins during the adenoviral infection 
process are listed in the Table 1.7. 
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Table 1.5 Protein interactions involving structural proteins during the adenovirus infection 
Viral protein Cellular protein  Functional significance  
Hexon 
Scavenger 
receptor II 
Facilitate the infection of Kupffer cells with HAdV-
5 (Khare et al., 2012) 
Hexon 
blood clotting 
factor X 
Recognition by innate immune system of the 
invading HAdV-5 (Doronin et al., 2012) 
Penton 
Bcl-2-associated 
athanogene 3 
Important for the cellular entry and progeny 
production in HAdV-2 infected cells (Gout et al., 
2010) 
Fiber GD1a ganglioside 
Infection of corneal cells with HAdV-37 (Nilsson et 
al., 2011) 
pVI Importin α/β Nuclear import of pVI (Wodrich et al., 2003) 
pIX Unknown 
Activation of TATA containing cellular and viral 
promoters (Lutz et al., 1997) 
pV 
Nucleolin and 
B23 
Displaces nuclear proteins during the HAdV-2 
infection process (Matthews, 2001) 
pVII 
Template-
activating factor I 
α (SET) 
Forms the complex with the viral chromatin in 
HAdV-5 infected cells (Xue et al., 2005) 
pVII 
Phosphoprotein 
32 (pp32) 
Forms the complex with the viral chromatin in 
HAdV-5 infected cells (Xue et al., 2005) 
pTP 
Octamer 
transcription 
factor 1 (Oct-1) 
Stimulate DNA replication (Coenjaerts et al., 1994) 
pTP 
Nuclear factor I 
(NFI) 
Positively influence the viral DNA replication 
(Coenjaerts et al., 1994) 
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Table 1.6 Protein interactions involving non-structural proteins during the adenovirus 
infection 
Viral protein Cellular protein  Functional significance  
E1A protein 
(289R) 
Transcription 
factor E2F/DP-1 
protein complex 
induction of S-phase in adenovirus infected cells 
(Pelka et al., 2011) 
E1A protein 
Forkhead box 
protein (FOX) 
K1/K2 
Supress cell proliferation and transformation in 
HAdV-5 infected cells (Komorek et al., 2010) 
E1A proteins 
(289R and 243R) 
Yin and yang 
(YY1) 
Relieving the repression by YY1 protein in infected 
cells (Lewis et al., 1995) 
E1A proteins 
(289R and 243R) 
BS69 
BS69 suppresses the E1A activated transcription in 
transfected cells (Hateboer et al., 1995) 
E1A protein 
Mediator of RNA 
polymerase II 
transcription 
subunit 23 
(mSur2) 
Plays an important role in the viral replication of 
mouse adenovirus type 1 (MAdV-1) (Fang et al., 
2004; Fang and Spindler, 2005) 
E1A protein 
Histone 
acetyltransferase 
p300 
Entry of infected cell into S-phase (Eckner et al., 
1994) 
E1A protein 
CREB binding 
protein (CBP) 
Suppression of myogenesis in HAdV-5 infected cells 
(Reid et al., 1998; O'Connor et al., 1999) 
E1A protein 
Dual-specificity 
Yak1-related 
kinases (DYRK) 
Cell cycle and tumorigenicity regulation (Zhang et 
al., 2001) 
E1A protein 
Cyclin-dependent 
kinase inhibitor 1 
(p21) 
Regulation of apoptosis in the transfected cells 
(Chattopadhyay et al., 2001) 
E1A protein 
Transcription 
factor p65 
Inhibition of transcriptional activation in HAdV-12 
infected cells (Jiao et al., 2010) 
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Table 1.6 cont. 
Viral protein Cellular protein  Functional significance  
E1A protein 
(289R) 
Histone 
acetyltransferase 
GCN5 
Negative regulation of transactivation in the 
transfection and knock-down assays (Ablack et al., 
2012) 
E1A protein 
PML nuclear 
bodies (PML-II) 
Transactivation of viral promoter of HAdV-5 
(Berscheminski et al., 2013) 
E1B-55K protein PCAF protein 
Resulting in the inhibition of p53 acetylation 
affecting the cellular transformation by HAdV-12 
(Liu et al., 2000) 
E1B-55K protein 
Wilms tumor 
protein (WT1) 
Inhibition of cellular apoptosis in transfected 
osteosarcoma cells (Maheswaran et al., 1998) 
E1B-55K protein p53 protein 
Functional inactivation of tumore suppressor p53 
(Maheswaran et al., 1998) 
E1B-55K protein Daxx 
Inhibition of p53 mediated transactivation of Bax 
promoter sequences (Zhao et al., 2003) 
E1B-55K protein mSin3A 
Co-repressor mSin3A protein interaction is not 
required for the p53 mediated transcriptional 
repression for HAdV-12 (Zhao et al., 2007) 
E1B-156R protein 
Daxx and p53 
proteins 
Unknown functional significance in the HAdV-5 
infected cells (Sieber and Dobner, 2007) 
E3-14.7K protein 
NF-kappa-B 
essential 
modulator (FIP-3) 
Prevents the cell apoptosis by FIP-3 in co-
transfected cells (Li et al., 1999) 
E3-ADP 
Mitotic arrest 
deficient 2-like 
protein 2 
(MAD2B) protein 
Important role in the cell lysis and mature virion 
release in HAdV-5 infected cells (Ying and Wold, 
2003) 
E4orf1 protein 
Disks large 1 
(Dlg1) 
May have role in tumorigenesis in the HAdV-9 
infected cells (Lee et al., 1997) 
E4orf1 protein 
Multiple PDZ 
domain protein 
(MUPP1) 
HAdV-9 infected cell transformation (Lee et al., 
2000) 
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Table 1.6 cont. 
Viral protein Cellular protein  Functional significance  
E4orf4 protein 
Yeast nucleoside 
diphosphatase 1 
(Ynd1) 
Apoptosis of the transformed yeast cells (Mittelman 
et al., 2010) 
33K protein 
DNA-dependent 
protein kinase 
(DNA-PK) 
DNA-PK negatively regulates the early to late L1 
alternative splicing (Tormanen Persson et al., 2012) 
33K protein 
Protein kinase A 
(PKA) 
PKA activates early to late L1 alternative splicing 
(Tormanen Persson et al., 2012) 
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Table 1.7 Protein interactions involving viral proteins during the adenovirus infection 
Viral protein Viral protein  Functional significance  
L1-52/55K protein IVa2 protein 
Transcription from MLP and viral assembly 
formation in HAdV-5 (Gustin et al., 1996) 
E1B-55K protein E1B-55K protein 
Homodimer formation important for association with 
the p53 protein in HAdV-5 infected cells 
(Morawska-Onyszczuk et al., 2010) 
E4orf6 protein E1B-55K protein 
HAdV-5 E1B-55K protein get translocated from 
cytoplasm to the nucleus in the presence of HAdV-5 
E4orf6 protein in cotransfected cells (Goodrum et al., 
1996) 
22K protein 22K protein 
The exact significance is unknown (Yang and Maluf, 
2010) 
E1A protein pVII 
Association is necessary for the recruitment of E1A 
protein to the transcription sites (Johnson et al., 
2004) 
IVa2 protein 33K 
Forms a trimeric complex with DBP to play an 
important role in viral genome packaging (Ahi et al., 
2013) 
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2.0 HYPOTHESIS AND OBJECTIVES 
2.1 Rationale for hypothesis 
 Adenoviruses have provided a model system for the study of the host-pathogen interactions 
since 1953 (Rowe et al., 1953). Most adenoviruses are non-pathogenic in nature but economically 
important infections like infectious canine hepatitis, kennel cough, egg drop syndrome, 
hydropericardium syndrome and haemorrhagic enteritis results from them. Like other 
adenoviruses, BAdV-3 is non-pathogenic and grows to high titers. Though molecular 
characterization of BAdV-3 has demonstrated similarities with other members of 
Mastadenoviruses (Baxi et al., 1998; Reddy et al., 1998; Reddy et al., 1999), recent studies 
identified distinct features of BAdV-3 (Patel and Tikoo, 2006; Xing and Tikoo, 2006; Kulshreshtha 
and Tikoo, 2008). Since the production of progeny virus involve both protein-DNA and protein-
protein interactions, many structural proteins, non-structural proteins and cellular proteins appear 
to be involved in these interactions (Russell, 2009). Determining the importance of these 
interactions would help not only in understanding the biology of BAdV-3 but may also help in 
designing an efficient vaccine delivery vehicle (Mittal et al., 1999; Babiuk and Tikoo, 2000; Reddy 
et al., 2000; Wu and Tikoo, 2004; Xing and Tikoo, 2006; Zakhartchouk et al., 2007). 
One of sixteen genus-common genes is the non-structural protein named 100K found in all 
the adenoviruses reported so far (Davison et al., 2003). Adenovirus 100K protein appears essential 
for the replication of the HAdV-5 (Hodges et al., 2001). Adenovirus 100K protein is involved in 
the trimerization of adenoviral hexon protein (Morin and Boulanger, 1986; Hong et al., 2005) and 
in translation of late viral mRNA using special initiation mechanism known as ribosomal shunting 
(Xi et al., 2004). Although, adenoviral 100K protein has been shown to interact with the cellular 
translation initiation factor eIF4G, (Cuesta et al., 2000), adenoviral hexon protein (Hong et al., 
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2005) and 33K protein, many functions performed by 100K may require interaction(s) with other 
cellular or viral proteins. 
2.2 Hypothesis 
 I hypothesize that BAdV-3 100K protein interacts with other viral and cellular proteins 
during the BAdV-3 infection of bovine cells. 
2.3 Objectives 
 The work presented in this thesis is directed to characterize the 100K protein and its 
interactions in BAdV-3. The following specific objectives were designed to test the hypothesis. 
i. To characterize the expression and localization pattern of the 100K protein in BAdV-3 infected 
and plasmid DNA transfected cells. 
ii. To identify the cellular and other viral protein partners interacting with the 100K protein of 
BAdV-3. 
iii. To attempt the identification of biological significance of observed protein-protein 
interactions. 
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3.0 INTERACTION BETWEEN 100K AND 33K PROTEINS OF BOVINE ADENOVIRUS-
3 
3.1 Introduction 
 Adenoviruses are non-enveloped, icosahedral, DNA viruses of the vertebrates with a genome 
size of 26-45 kbp (Davison et al., 2003; San Martin, 2012). Bovine adenovirus (BAdV)-3 belongs 
to the genus Mastadenovirus and is being characterized in detail to develop it as gene delivery 
vector for cattle and humans (Zakhartchouk et al., 1999; Zakhartchouk et al., 2007; Du and Tikoo, 
2010). Adenoviral genes can be classified as the early, intermediate and late based on the onset of 
their expression before or after the viral DNA replication. Early proteins are responsible for the 
control of cell cycle and viral protein expression leading to viral DNA replication (Berk, 2007). 
The late viral proteins are transcribed from the adenoviral major late promoter (MLP) after the 
viral DNA replication. Seven families of late genes, named L1 to L7 based on the common poly 
(A) signal are present in BAdV-3 (Reddy et al., 1998). 
 The BAdV-3 L1 family of transcripts synthesizes the four proteins namely 52K, IIIa, penton 
base and pVII (Reddy et al., 1998). The L2, L3 and L4 region of BAdV-3 codes for one protein 
each, protein V, protein X and protein VI, respectively (Reddy et al., 1998). The L5 region of 
BAdV-3 codes for two proteins namely hexon and adenoviral protease (Reddy et al., 1998). 
BAdV-3 L6 family encode four proteins namely 100K, 33K, 22K and pVIII (Reddy et al., 1998; 
Kulshreshtha and Tikoo, 2008). The L7 region of BAdV-3 codes for the fiber protein (Reddy et 
al., 1998). 
 Human adenovirus 100K protein, expressed at late times post infection (Cepko and Sharp, 
1982) localizes to nucleus and cytoplasm (Gambke and Deppert, 1981). It is involved in translation 
of cellular and late adenovirus mRNAs (Cuesta et al., 2000; Xi et al., 2004), and helps in 
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trimerization and nuclear localization of hexon protein (Hong et al., 2005).  Not much is known 
about BAdV-3 100K. Recently, we demonstrated that the 100K protein can interact with the 33K 
protein in BAdV-3 infected MDBK cells (Kulshreshtha and Tikoo, 2008). In this report, we 
describe the molecular characterization of the BAdV-3 100K protein and identified the necessary 
region for interacting with 33K protein. 
3.2 Materials and methods 
3.2.1 Cell lines and viruses 
 Madin-Darby bovine kidney (MDBK) cells were grown in the minimum essential medium 
(MEM) (HyClone® Laboratories, Inc.) with 10 % fetal bovine serum (FBS) (PAA Laboratories 
Inc.), 10 mM HEPES buffer (Life Technologies), 0.1 mM non-essential amino acids (NEAA) (Life 
Technologies), and 50μg/ml gentamicin (HyClone® Laboratories, Inc.). 293T (a human 
embryonic kidney) cells and Vero cells were grown in the Dulbecco's modified Eagle medium 
(DMEM) (HyClone® Laboratories, Inc.) with 10 % FBS, 10 mM HEPES buffer, 0.1 mM NEAA 
and 50 μg/ml gentamicin. The wild-type BAdV-3 (WBR-1 strain) was propagated as described 
(Reddy et al., 1998). 
3.2.2 Antibody production 
 The anti-100K antibodies were generated using peptides synthesized on the Pioneer Peptide 
Synthesis System (Perkin Elmer). Two peptides corresponding to the N-terminus (amino acids 
102-126) and C-terminus (amino acids 776-790) of BAdV-3 100K protein were synthesized and 
conjugated to keyhole limpet hemocyanin (KLH). Two rabbits were first injected with the 
individual peptide (500 μg/ rabbit) with Freund’s complete adjuvant at day 1 by intradermal route. 
Peptides with the Freund’s incomplete antigen were injected on 14th, 28th and 42nd day by 
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subcutaneous route to the rabbits. The serum was collected on 63rd day and presence of anti-100K 
antibodies was verified by immunoprecipitation analysis. 
3.2.3 Analysis of 100K amino acid sequence  
The amino acid sequence of 100K protein was analyzed using COILS prediction program 
(Lupas et al., 1991). Five coiled-coil regions were identified in the 100K protein between amino 
acids 121-163, 234-280, 338-370, 463-497 and 680-706. 
Online program NUCDISC PSORT II (Nakai and Horton, 1999) predicted the subcellular 
localization signals of BAdV-3 100K protein. One bipartite (amino acids 794-810) nuclear 
localization signal was predicted by NUCDISC PSORT II from 100K amino acid sequence. The 
online software, eukaryotic linear motifs (ELM), (Dinkel et al., 2012) was used for the prediction 
of the functional sites of interacting amino acid sequence. The homology of amino acid sequences 
was generated with the Clustal W program (Larkin et al., 2007). 
3.2.4 Plasmid construction 
The plasmids p33K.DR, pGBKT7.33K, pGADT7.33K and pGEX-33K (spliced 33K gene 
of BAdV-3) (Kulshreshtha and Tikoo, 2008) were a kind gift from Dr. Vikas Kulshrestha. 
Bimolecular fluorescence complementation (BiFC) plasmids pGN and pGC were gift from Dr. 
Abraham Loyter (The Hebrew University of Jerusalem, Israel) (Levin et al., 2009). Plasmids were 
constructed using standard molecular techniques (Sambrook and Russell, 2000) and confirmed by 
DNA sequencing.  
(a) pcDNA.b100K. A 2550 bp DNA fragment containing 100K ORF was amplified by PCR using 
the primers b100K·F and b100K·R (Table 3.1), and plasmid pFBAV302 (Zakhartchouk et al., 
1998) DNA as a template. The PCR product was digested with HindIII-XbaI and ligated to 
HindIII-XbaI digested plasmid pcDNA3.1 (+) (Invitrogen) creating plasmid pcDNA.b100K. 
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(b) pb100K.EY. A 2550 bp DNA fragment containing100K ORF was amplified by PCR using 
primers b100EY·F and b100EY·R (Table 3.1), and plasmid pFBAV302 (Zakhartchouk et al., 
1998) DNA as a template. The PCR product was digested with HindIII-AgeI and ligated to 
HindIII-AgeI digested plasmid pEYFP-N1 (Clontech) creating plasmid pb100K.EY. 
(c) pHA.b100K. Two complementary oligonucleotides (HA·Link1 and HA·Link2) (Table 3.1) 
designed to encode HA epitope with four base overhangs compatible with HindIII cut site were 
annealed to create the linker. HA epitope coding linker was ligated to HindIII digested plasmid 
pcDNA.b100K creating plasmid pHA.b100K. 
(d) pGBKT7.b100K. A 2550 bp DNA fragment containing 100K ORF was amplified by PCR using 
the primers GBKb100K·F and GBKb100K·R (Table 3.1), and plasmid pcDNA.b100K DNA 
as a template. The amplified product was digested with NdeI-EcoRI and ligated to NdeI-EcoRI 
digested plasmid pGBKT7 (Clontech) creating plasmid pGBKT7.b100K. 
(e) pGADT7.b100K. A 2550 bp DNA fragment containing 100K ORF was amplified by PCR 
using the primers GBKb100K·F and GBKb100K·R (Table 3.1), and plasmid pcDNA.b100K 
DNA as a template. The amplified product was digested with NdeI-EcoRI and ligated to NdeI-
EcoRI digested plasmid pGADT7 (Clontech) creating plasmid pGADT7.b100K. 
(f) pcDNA.b100K(1-624). A 1494 bp DNA fragment containing the N-terminus 624 amino acids 
coding region of 100K gene was PCR amplified using primers b100K·F and b100K(1-624)·R 
(Table 3.1), and plasmid pcDNA.b100K DNA as a template. The amplified PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(1-624). 
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Table 3.1 List of oligonucleotides 
Oligo name Sequence (5′-3′)a 
b100K·F AGACCCAAGCTTATGGCAGAGAAAGGCAGTGAAAATC 
b100K·R GGGCCCTCTAGACTACTCTTCTTGCCCTGGCC 
HA·Link1 AGCTGAATTCGCCGCCATGGATTACCCATACGACGTACCAGATTACGCTA 
HA·Link2 AGCTTAGCGTAATCTGGTACGTCGTATGGGTAATCCATGGCGGCGAATTC 
GBKb100K·F GAATTCCATATGATGGCAGAGAAAGGCAGTG 
GBKb100K·R ACTATGGAATTCCTACTCTTCTTGCCCTGGCCCTTCTT 
b100EY·F GAGCTCAAGCTTATGGCAGAGAAAGGCAGTGAAAATC 
b100EY·R GTGGCGACCGGTCTCTTCTTGCCCTGGCCCTTC 
b100K(1-624)·R TATACCTCTAGACTACTGAATCTCGAAGGTACCGA 
b100K(1-637)·R TATACCTCTAGACTAGGGCGGTTTGGTCGGCTGTC 
b100K(624-637d)·F ACCATAGCTCAAGACCTAGGTCTCATGGAATGCTACTGTCGC 
b100K(624-637d)·R GCGACAGTAGCATTCCATGAGACCTAGGTCTTGAGCTATGGT 
CAT.SbfI.F CCTGCAGGTACCCAATACTCTTCATC 
CAT.SbfI.R CCTGCAGGTAAGCTGCAATAAACAAG 
b100K(121-163d)·F CGCGACGAGGCCTTCGTACGTGCCCAAGGTACCACCCAAGAAG 
b100K(121-163d)·R CTTCTTGGGTGGTACCTTGGGCACGTACGAAGGCCTCGTCGCG 
b100K(234-280d)·F GACTCCTTACCGTGCTTCCCCACACTGTCTTTGACACATTTCG 
b100K(234-280d)·R CGAAATGTGTCAAAGACAGTGTGGGGAAGCACGGTAAGGAGTC 
b100K(338-370d)·F GACCCTGAACTTGCTCGCTGGGAGTGCCTGCACAAGTTTTTT 
b100K(338-370d)·R AAAAAACTTGTGCAGGCACTCCCAGCGAGCAAGTTCAGGGTC 
b100K(463-497d)·F CAGACTGCCATGGGCATTTGGCTAGCTGACATAGTGTTCCCCC 
b100K(463-497d)·R GGGGGAACACTATGTCAGCTAGCCAAATGCCCATGGCAGTCTG 
b100K(680-706d)·F AAAGCCGAAAGTGACCCCCAGCGCTCACGGAGTGTATCTGGACC 
b100K(680-706d)·R GGTCCAGATACACTCCGTGAGCGCTGGGGGTCACTTTCGGCTTT 
GN·b100K·F TGTCGCCCCGGGATGGCAGAGAAAGGCAGTGAAAATCAGC 
GN·b100K·R AAAGCTGAATTCCTACTCTTCTTGCCCTGGCCCTTC 
GC·b33K·F GTCGACCCCGGGATGAAACCCCGCAGCATGTCGGCAGC 
GC·b33K·R AAAGGCCGCGGCCGCTTAGGCGGGTCCGGATTCGTCC 
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Table 3.1 cont 
Oligo name Sequence (5′-3′)a 
b100K·742·F1 GCTTGTGTCATCACTGAAGAAAAAGTTTTAG 
b100K·742·R2 AGGGCGAGGGCGCGCCGCGCTGGCACTCCGGCGGCTC 
b100K·742·R1 GTCCAGAGACCTGCAGTCAGCCTTAAGATCTCGAAGGTACCGATAAC 
b100K·742·F2 GTTATCGGTACCTTCGAGATCTTAAGGCTGACTGCAGGTCTCTGGAC 
a Restriction enzyme sites are underlined. 
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(g) pcDNA.b100K(1-637). A 1938 bp DNA fragment containing the N-terminus 637 amino acids 
of 100K gene was amplified by PCR using the primers b100K·F and b100K(1-637)·R (Table 
3.1), and plasmid pcDNA.b100K DNA as a template. The amplified PCR product was digested 
with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) creating 
plasmid pcDNA.b100K(1-637). 
(h) pcDNA.b100K(624-637d). A 822 bp fragment of 100K gene was amplified by PCR using the 
primers b100K·F and b100K(624-637d)·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. Secondly, a 1530 bp fragment of 100K gene was amplified by PCR using the primers 
b100K(624-637d)·F and b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(624-637d). 
(i) pcDNA.b100K(121-163d)c1. A 393 bp fragment of 100K gene was amplified by PCR using 
the primers b100K·F and b100K(121-163d)·R (Table 3.1), and plasmid pcDNA.b100K DNA 
as a template. Secondly, a 2098 bp fragment of 100K gene was amplified by PCR using the 
primers b100K(121-163d)·F and b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA b100K(121-163d)c1. 
(j) pcDNA.b100K(234-280d)c2. A 733 bp fragment of 100K gene was amplified by PCR using 
the primers b100K·F and b100K(234-280d)·R (Table 3.1), and plasmid pcDNA.b100K DNA 
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as a template. Secondly, a 1746 bp fragment of 100K gene was amplified by PCR using the 
primers b100K(234-280d)·F and b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(234-280d)c2. 
(k) pcDNA.b100K(338-370d)c3. A 1044 bp fragment of 100K gene was amplified by PCR using 
the primers b100K·F and b100K(338-370d)·R (Table 3.1), and plasmid pcDNA.b100K DNA 
as a template. Secondly, a 1476 bp fragment of 100K gene was amplified by PCR using the 
primers b100K(338-370d)·F and b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(338-370d)c3. 
(l) pcDNA.b100K(463-497d)c4. A 1420 bp fragment of 100K gene was amplified by PCR using 
the primers b100K·F and b100K(463-497d)·R (Table 3.1), and plasmid pcDNA.b100K DNA 
as a template. Secondly, a 1095 bp fragment of 100K gene was amplified by PCR using the 
primers b100K(463-497d)·F and b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(463-497d)c4. 
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(m) pcDNA.b100K(680-706d)c5. A 2068 bp fragment of 100K gene was amplified by PCR using 
the primers b100K·F and b100K(680-706d)·R (Table 3.1), and plasmid pcDNA.b100K DNA 
as a template. Secondly, a 472 bp fragment of 100K gene was amplified by PCR using the 
primers b100K(680-706d)·F and b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(680-706d)c5. 
(n) pGN.b100K. A 2550 bp DNA fragment containing 100K ORF was amplified by PCR using 
the primers GN·b100K·F and GN·b100K·R (Table 3.1), and plasmid pcDNA.b100K DNA as 
a template. The PCR amplified product was digested with XmaI-EcoRI and ligated to XmaI-
EcoRI digested plasmid pGN (Levin et al., 2009) creating plasmid pGN.b100K. 
(o)  pGC.33K. A 837 bp DNA fragment containing 33K ORF was amplified by PCR using the 
primers GC·33K·F and GC·33K·R (Table 3.1), and plasmid pFBAV302 (Zakhartchouk et al., 
1998) DNA as a template. The PCR amplified product was digested with XmaI-NotI and 
ligated to XmaI-NotI digested plasmid pGC (Levin et al., 2009) creating plasmid pGC.33K. 
3.2.5 Construction of full length BAdV-3 genomic clone expressing mutant 100K protein in 
a plasmid 
(a) pUC18.BAV3.100K. A 9962 bp EcoRV-NdeI fragment of plasmid pUC304a+ (Du and Tikoo, 
2010) was digested with SalI. A 6477 bp SalI-EcoRV fragment was isolated and ligated to 
SalI-SmaI digested plasmid pUC18 creating plasmid pUC18.BAV3.100K. 
(b) pUC18.BAV3.CAT.SbfI. A 894 bp DNA fragment containing chloramphenicol 
acetyltransferase (CAT) cassette was amplified by PCR using the primers CAT.SbfI.F and 
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CAT.SbfI.R (Table 3.1), and plasmid pBAC-lacZ (Addgene plasmid) DNA as a template. The 
PCR product was digested with NheI-AfeI (end filled-in) and ligated to NheI-AfeI (end filled-
in) digested plasmid pUC18.BAV3.100K creating plasmid pUC18.BAV3.CAT.SbfI. 
(c) pUC304a.CAT.SbfI∆100K. A 4491 bp BamHI DNA fragment of plasmid 
pUC18.BAV3.CAT.SbfI was isolated and recombined with MfeI digested plasmid pUC304a 
(Du and Tikoo, 2010) in BJ5183 E. coli cells creating plasmid pUC304a.CAT.SbfI∆100K. 
(d) pUC304a∆100K. Plasmid pUC304a.CAT.SbfI∆100K DNA was digested with SbfI and self-
ligated to create plasmid pUC304a∆100K. 
(e) pUC18.100K.624-637d. A 219 bp DNA fragment of 100K gene was amplified by PCR using 
primers b100K·742·F1 and b100K·742·R1 (Table 3.1), and plasmid pUC18.BAV3.100K 
DNA as a template. Secondly, a 631 bp DNA fragment of 100K gene was amplified by PCR 
using primers b100K·742·F2 and b100K·742·R2 (Table 3.1), and plasmid 
pUC18.BAV3.100K DNA as a template. The third PCR was performed using the primers 
b100K·742·F1 and b100K·742·R2 (Table 3.1) and both previously amplified annealed PCR 
products as a template. The PCR product was digested with AscI and ligated to AfeI-AscI 
digested plasmid pUC18.BAV3.100K creating plasmid pUC18.100K.624-637d. 
(f) pUC304a.624-637d. A 5122 bp SalI-ClaI DNA fragment of plasmid pUC18.100K.624-637d 
was recombined with SbfI digested plasmid pUC304a∆100K in BJ5183 E. coli creating 
plasmid pUC304a.624-637d. 
(g) pUC304aΔ100K Rev1. A 6163 bp SalI-BglII DNA fragment of plasmid pUC18.BAV3.100K 
was recombined with MfeI digested plasmid pUC304a∆100K in BJ5183 E. coli creating 
plasmid pUC304aΔ100K Rev1. 
 44 
(h) pUC304a.624-637d Rev2. A 6163 bp SalI-BglII DNA fragment of plasmid 
pUC18.BAV3.100K was recombined with MfeI digested plasmid pUC304a.624-637d in 
BJ5183 E. coli creating plasmid pUC304a.624-637d Rev2. 
3.2.6 Transfection 
 The 293T or Vero cells (70-80% confluent) in the 24-well plate or chambered glass slides 
were washed with OptiMEM® (Life Technologies). After 3h of incubation, the cells were 
transfected with respective plasmid DNA (2 μg/well; 2 μg/chamber) using LipofectamineTM 2000 
(Life Technologies) as per manufacturer’s instructions.  
3.2.7 Western blot analysis 
 MDBK cells were infected with virus at an MOI of 5. At indicated times post infection, the 
cells were washed once in PBS pH 7.4 (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM 
KH2PO4) and lysed for 30 min in radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris (pH 8)) with 
protease inhibitors (aprotinine, leupeptin, pepstatin A 1 μg/mL each). Proteins from the lysates of 
the cells were separated by 15% SDS PAGE, blotted on nitrocellulose membrane (Bio-Rad, 162-
0115) and probed with primary antibody (anti-100K or anti-actin) followed by alkaline 
phosphatase conjugated secondary antibodies as described (Kulshreshtha et al., 2004). Finally, 
BCIP®/NBT solution (Sigma, B6404) was used as substrate to visualize the protein bands of 
interest on the nitrocellulose membrane. 
3.2.8 Yeast two-hybrid system 
 Initially, Yeast Matchmaker GAL4 Two-Hybrid System (Clontech) was used to confirm 
interaction between 100K and 33K protein of BAdV-3. Assay was performed according to the 
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supplier’s instruction manual (Clontech). Briefly, equal amount (0.1µg) of bait and prey plasmid 
DNA were co-transformed into AH109 strain of Saccharomyces cerevisiae cells using salmon 
sperm DNA as carrier employing lithium acetated based method. Three selective dropout agar 
plates (-Leu/-Trp, -Leu/-Trp/-His, -Leu/-Trp/-His/-Ade/X-alpha-Gal) were plated with 
transformants for growth and color development. Leaky expression of His3 was prevented by 
adding competitive inhibitor of His3, 3-amino-1,2,4-triazole (Sigma) at 5 mM concentration to -
Leu/-Trp/-His and -Leu/-Trp/-His/-Ade/X-alpha-Gal dropout plates. Plates were incubated at 30°C 
in the humidified incubator for the period of 7 days. Plasmid pair pGBKT7.p53 and pGADT7.T 
served as positive control and plasmid pair pGBKT7.Lam and pGADT7.T was used as negative 
control as per manufacturer’s instructions.  
3.2.9 GST pull down assay 
 E. coli BL21 (DE3) pLysS (Promega) cells were transformed with plasmid pGEX-33K 
(Kulshreshtha and Tikoo, 2008) or pGEX-5X-1 DNA. The GST or GST-33K protein expression 
was induced by adding 0.5mM isopropyl β-D-1-thiogalactopyranoside (IPTG) (Sigma) to the 
exponentially growing bacterial culture on shaking incubator for 3 h at 37 °C. The proteins were 
purified, immobilized on Glutathione-Sepharose beads (Pharmacia), as described (Zhou et al., 
2001) Protein concentration of the purified GST fusion protein was estimated by Bradford assay 
(Bradford. 1976). Identities of purified proteins were determined by Western blot analysis. 
 TNT T7 Coupled Reticulocyte Lysate System (Promega) was used for in vitro transcription 
and translation (IVTT) of individual plasmid DNA (1 µg) in the presence of 30 µCi of [35S] 
methionine as per manufacturer’s protocol in 50µl volume. About 15 µg of purified GST or GST-
33K protein and 20 µl of IVTT product were added to the 40 µl of glutathione bead slurry (50%) 
in separate tubes and incubated on nutator for overnight at 4°C in total volume of 500 µl GST 
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binding buffer. Unbound IVTT product was removed by four washes (five minutes each) with 500 
µl GST binding buffer on nutator at 4 °C. Finally, the beads were resuspended in 30 µl of 5X SDS 
sample buffer. Interacting radiolabelled protein was separated by 8% SDS-PAGE analysis, 
exposed overnight to phosphorimaging screen (Kodak) and visualized on Molecular Imager FX 
(Bio-Rad) using Quantity One software (Bio-Rad). 
3.2.10 Bimolecular fluorescence complementation assay 
 The assay was performed as described previously with minor modifications (Levin et al., 
2009). Plasmid DNA encoding the fusion proteins of N and C-terminus of green fluorescent 
protein (GFP) were cotransformed into yeast cells. Yeast transformation mixture were plated on 
the uracil and histidine deficient agar plates in humidified incubator at 30 °C for 5 days. A few 
colonies from each plate were resuspended into the 1 ml of PBS and washed 5 times. Yeast cells 
were fixed in 4% paraformaldehyde for 30 minutes at room temperature, and permeabilized by 
0.5% Triton X-100 in PBS for 15 minutes. Cells were transferred onto the glass slide and mounted 
with VECTASHIELD® mounting medium (Vector Laboratories, H-1200). Cells were observed 
under the Zeiss LSM 5 confocal microscope (Carl Zeiss) for the identification of interaction. 
3.2.11 Immunofluorescence microscopy 
 MDBK infected with wild-type BAdV-3 at an MOI of 1 or Vero cells transfected with 
plasmid DNA (2 μg/coverslip). Forty eight hours post transfection/infection, the cells were fixed 
in 4% paraformaldehyde in PBS for 30 minutes at room temperature, and permeabilized by 0.5% 
Triton X-100 in PBS for 15 minutes. The cells were stained with anti-100K sera and stained with 
Cy2 AffiniPure Goat Anti-Rabbit IgG (Jackson ImmunoResearch Laboratories). The cells were 
washed in PBS three times each for 10 minutes and later counter stained with 4',6-diamidino-2-
phenylindole (DAPI) followed by three more washes. Finally, the coverslips were mounted with 
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Citifluor AF4 mounting media. Images were captured using different laser lines under laser 
scanning confocal microscope (Zeiss LSM410). 
3.3 Results 
3.3.1 Expression of 100K protein 
 Protein specific antisera designated N100 (against N-terminus peptide) and C100 (against 
C-terminus peptide), generated separately in rabbits was used to characterize 100K protein in gene 
transfected or BAdV-3 infected cells by Western blot analysis (Fig. 3.1). Anti-HA monoclonal 
antibody recognized a doublet of 130 kDa in plasmid pHA.b100K transfected cells (panel A). No 
such protein could be detected in plasmid pc.HA (pcDNA containing HA tag) transfected cells. 
Anti-100K (N100+C100) sera detected a protein of 130 kDa in BAdV-3 infected cells from 24-48 
hrs post infection (panel B). Moreover, additional bands of 100 kDa, 95 kDa and 15 kDa were also 
detected at 36-48 hrs post infection which may be due to post-translational modification or protein 
cleavage. No such proteins could be detected at 0-12 hrs post infection. Earlier, 33K protein was 
detected at the 24, 36 and 48 hrs post infection as a protein of 42 kDa in infected cell lysates 
(Kulshreshtha et al., 2004). Moreover, additional bands of 33 and 38 kDa were also detected at 36-
48 hrs post infection (Kulshreshtha et al., 2004). 
3.3.2 Sub-cellular distribution of 100K 
 To determine subcellular localization of proteins in infected cells, MDBK cells on the glass 
coverslips were infected with BAdV-3 at an MOI of 5. At 48 hrs post infection, the cells were 
examined by indirect immunofluorescence using protein specific sera. As seen in figure 3.2A, anti-
100K (N100+C100) sera detected protein in the nucleus and cytoplasm of infected cells. Similarly,  
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Figure 3.1 Expression of 100K protein. Proteins from the lysates of 293T cells transfected with 
indicated plasmid DNAs (panel A) collected after 48 hrs post transfection or BAdV-3 infected 
MDBK, collected at indicated times post infection (panel B) were separated by 12 % SDS-PAGE, 
transferred to nitrocellulose and probed in Western blot using anti-HA monoclonal antibody 
(panel A) or anti-100K sera (N100+C100) + anti-β actin monoclonal antibody (panel B). 
Molecular weight markers are shown on the left of the panel. 
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anti-33K (Kulshreshtha and Tikoo, 2008) detected protein predominantly localized in the nucleus 
of infected cells.  
 To determine the subcellular localization of proteins in transfected cells, Vero cells were 
transfected with indicated plasmid DNA. At 48 hrs post transfection, cells were examined by direct 
fluorescence. As seen in figure 3.2B 100K-EYFP fusion protein localized predominantly in the 
cytoplasm of plasmid pb100K.EY DNA transfected Vero cells. Similarly, anti-HA (MAb) detected 
HA tagged 100K predominantly in the cytoplasm of the plasmid pHA.b100K DNA transfected 
cells. However, 33K-DsRed fusion protein localized predominantly in the nucleus of the 
transfected cells. 
3.3.3 Interaction of 100K and 33K protein of BAdV-3 
 To reconfirm the interaction of 100K protein with 33K protein, initially yeast two-hybrid 
assay was performed. The plasmid pGBKT7.100K and pGADT7.33K DNAs were cotransformed 
in the AH109 and grown on selective drop out media. The positive interaction was identified by 
the presence growth and the green color development. The reverse yeast two-hybrid assay was 
performed using plasmid DNA pGADT7.100K and pGBKT7.33K and the interaction was 
confirmed as growth and color development on selective drop out media. The plasmid positive and 
negative controls were used as per manufacturer’s instructions. As seen in figure 3.3, 100K 
interacted with 33K protein. 
 Secondly, we tested the interaction of 100K with 33K by GST pull-down assay. Purified 
GST or GST-33K (Fig. 3.4, panel A) bound to glutathione Sepharose beads were individually 
incubated with in vitro translated [35S] labeled 100K for 4 hrs at 4°C. The bound products were 
separated by 10 % SDS-PAGE and visualized by phosphorimager. As seen in figure 3.4 (panel B), 
in vitro translated labeled 100K bound to GST-33K but not to GST alone.  
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Figure 3.2 Subcellular distribution of BAdV-3 100K protein in infected and transfected cells. 
(A) BAdV-3 infected MDBK cells were processed at 48 h p.i. for confocal microscopy analysis 
for subcellular distribution of 100K protein (green) using anti-100K or anti-33K primary antibody 
and Cy2 AffiniPure Goat Anti-Rabbit IgG as secondary antibody (see Materials and Methods). 
Nuclear demarcation was achieved by staining with DAPI (blue). (B) Vero cells were transfected 
with plasmid DNA mentioned on the left side were processed at 48 h p.t. for confocal microscopy 
analysis for subcellular distribution of 100K protein (green) or 33K protein (red). 
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Figure 3.3 Confirmation of interaction of 100K-33K proteins using yeast two-hybrid assay. 
The AH109 cells were transformed with the bait and prey plasmids (mentioned on the right side 
of each photograph) and plated on the –leucine, –tryptophan, –histidine, –adenine plates 
supplemented with the X-alpha-gal. Plasmids pGBKT7.p53 and pGADT7.T were used as positive 
controls for the assay. 
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 Finally, the interaction between 100K and 33K proteins was confirmed using the bimolecular 
fluorescence complementation assay. The 100K protein coding DNA was fused in-frame with the 
N-terminal half of GFP protein coding region to create the plasmid pGN.100K. The spliced 33K 
protein coding DNA was fused in-frame with the C-terminal half of GFP protein coding region to 
create the plasmid pGC.33K. The co-transformants were analyzed by confocal microscopic 
examination and the green fluorescence was visible indicating the interaction between the 100K 
and 33K proteins of BAdV-3. As seen in figure 3.5, yeast cells co-transformed with 
pGN.100K+pGC.33K showed green fluorescence. No such fluorescence could be observed in 
yeast cells co-transformed with pGN.100K + pGC.33K or pGC.33K + pGN. 
3.3.4 Co-expression of 100K and 33K proteins 
 To determine if interaction between 100K and 33K proteins alters the subcellular distribution 
of 100K protein in transfected cells, Vero cells were co-transfected with plasmid  (pb100K.EY 
and p33K.DR) DNAs using the lipofectamine 2000 reagent and analyzed by direct fluorescence 
after 48 hrs of transfection. As seen in figure 3.5 (panel B), co-expression of 33K-DsRed fusion 
protein did not alter the predominant cytoplasmic localization of 100K-EYFP fusion. 
3.3.5 Identification of 100K protein domain interacting with 33K protein 
 To determine the domain of 100K interacting with 33K, initially we constructed plasmids 
containing deletions of individual coil-coil regions of 100K (Fig. 3.6, panel A) and analyzed 
interactions using GST-pull down assay. The deletions were analyzed by DNA sequencing and 
Western blot analysis using anti-100K (N100+C100) (Fig. 3.6 panel B).  In vitro transcribed and 
translated (in the presence of 30 μCi of [35S] methionine) mutant 100K proteins were individually 
incubated with GST or GST fusion proteins bound to Glutathione Sepharose beads. The bound  
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Figure 3.4 GST pull-down assay. (A) Purified proteins were separated by 10 % SDS-PAGE and 
analyzed by immunoblotting using anti-GST serum. The position of the molecular weight markers 
in kDa is shown to the left of the panel. (B) The in vitro transcribed/translated radiolabelled 100K 
protein was incubated with the purified GST alone or GST-33K fusion protein. The bound protein 
was separated by 10 % SDS PAGE and visualized by exposure to the phoshorimager screen. Input 
radiolabelled protein was 5% of the reaction volume. The molecular weights in kDa are indicated 
on the left side of the figure. 
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Figure 3.5 Confirmation of 100K protein interaction with 33K protein and its effect on 
localization. (A) Yeast cells were co-transformed with the indicated plasmid DNAs. Co-
transformed cells were plated on the uracil and histidine deficient agar plates and grown at 30° C 
for 5 days and processed for confocal microscopy for the presence of the green fluorescence. 
Empty vector pGN and pGC were used as negative controls for the self-complementation. (B) 
Vero cells were co-transfected with the plasmid pb100K.EY and p33K.DR DNA and processed at 
48 hrs p.t for confocal microscopy analysis. 
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labeled proteins were separated by 10 % SDS-PAGE and visualized by phosphorimager. As seen 
in figure 3.6 (panel C), all mutant 100K proteins bound to GST-33K fusion protein. 
 Next, we constructed two plasmids expressing truncated 100K proteins (Fig. 3.7, panel A, 
B) and analyzed the interaction of these proteins with GST-33K in GST-pull down assay. As seen 
in figure 3.7C, wild-type 100K or mutant 100K (expressing amino acids 1-637) interacts with 
GST-33K fusion protein. In contrast, no interaction could be detected between mutant 100K 
(expressing amino acids 1-624) and GST-33K fusion protein. No interaction was detected between 
wild-type or mutant 100K proteins and GST alone.  Based on these results, a GST pull-down assay 
was performed with mutant 100K containing deletion between amino acid 624-637. As seen in 
figure 3.7 (panel C), mutant 100K containing deletion of amino acid 624-637 abolished the 
interaction of 100K protein with 33K.  
 To validate these results in vivo, a bimolecular fluorescence complementation assay was 
performed. As seen in figure 3.8, green fluorescence could be observed in yeast cells 
cotransformed with plasmid pGN.100K+pGC.33K DNAs or pGN.100K(1-637) + pGC.33K 
DNAs. No such fluorescence could be observed in yeast cells cotransformed with plasmid pGN. 
100K (1-624) + pGC.33K; pGN.100(624-638)+ pGC.33K, pGN100K + pGC or pGN + pGC.33K 
DNAs. 
3.3.6 Isolation and analysis of BAdV-3 expressing mutant 100K protein 
The construction of plasmid pUC304a+ has been described (Du and Tikoo, 2010). Using 
recombination machinery of E. coli (Chartier et al., 1996), we constructed full length plasmids a) 
pUC304a∆100K mutant 100K protein (deletion of amino acid 19 to 678), b) pUC304a.624-637 
expressing mutant 100K (deletion of amino acids 624-637). We also constructed revertants a) 
pUC304a∆100K Rev1 expressing wild-type 100K and b) pUC304a.624-637 Rev2 expressing wild 
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Figure 3.6 Interaction of coiled coils deletions of 100K proteins with GST-33K protein by 
GST pull-down assay. (A) Schematic representation of the plasmid DNA. The amino acid 
numbers are depicted on the top of each construct. The name of the protein is depicted on the left 
of the panel. (B) Proteins from the lysates of indicated plasmid DNA transfected 293T cells 
collected after 48 hrs post transfection were separated by 10 % SDS-PAGE, transferred to 
nitrocellulose and probed in Western blot using anti-100K (N100+C100) sera. (C) The in vitro 
transcribed/translated [35S] labelled indicated proteins were incubated with the purified GST alone 
or GST-33K proteins. The bound proteins were separated by 10 % SDS PAGE and visualized by 
exposure to the phoshorimager screen. Input radiolabelled protein was 5% of the reaction volume. 
The molecular weights are indicated on the left side of the figures as numerals in kDa; c1 [pcDNA 
b100K(121-163d)c1]; c2 [pcDNA.b100K(234-280d)c2]; c3 [pcDNA.b100K(338-370d)c3]; c4 
[pcDNA.b100K(463-497d) c4]; c5 [pcDNA.b100K(680-706d)c5]; 100K [pcDNA.b100K]. 
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Figure 3.7 Identification of 100K protein region interacting with GST-33K protein by GST 
pull-down assay. (A) Schematic representation of the plasmid DNA. The amino acid numbers are 
depicted on the top of each construct. The name of the protein is depicted on the left of the panel. 
(B) Proteins from the lysates of indicated plasmid DNA transfected 293T cells collected after 48 
hrs post transfection were separated by 10 % SDS-PAGE, transferred to nitrocellulose and probed 
in Western blot using anti-100K (N100+C100) sera. (C) The in vitro transcribed/translated [35S] 
labelled indicated proteins were incubated with the purified GST alone or GST-33K proteins. The 
bound proteins were separated by 10 % SDS PAGE and visualized by exposure to the 
phoshorimager screen. Input radiolabelled protein was 5% of the reaction volume. The molecular 
weights are indicated on the left side of the figures as numerals in kDa; 637 [pcDNA b100K(1-
637)]; 624 [pcDNA.b100K(1-624)]; (624-637d) [pcDNA.b100K (624-637d)]; 100K 
[pcDNA.b100K]. 
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Figure 3.8 Interaction of 100K-33K proteins using bimolecular fluorescence assay. Yeast cells 
were co-transformed with the plasmids mentioned on left side of each panel. Co-transformed cells 
were plated on the uracil and histidine deficient agar plates and grown at 30° C for 5 days and 
processed for confocal microscopy for the presence of the green fluorescence. Empty vector pGN 
and pGC were used as negative controls for the self complementation. 
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-type 100K. The desired mutation was confirmed by restriction enzyme analysis (data not shown) 
and DNA sequencing of recombinant plasmid DNAs. The plasmid pUC304a+, pUC304a∆100K 
Rev1 or pUC304a.624-627 Rev2 DNAs when individually transfected into VIDO DT1 (Du and 
Tikoo, 2010) cells produced cytopathic effects in 14 days. Restriction enzyme analysis of virion 
DNA and growth in MDBK cells suggested that wild-type and revertant BAdV-3 possess similar 
characteristics. However, repeated (7 times) transfection of VIDO DT1 cells with varying amounts 
of plasmid pUC304a.624-637 DNA did not produce cytopathic effects even after four weeks of 
transfection. 
3.4 Discussion 
Protein-protein interactions play an important role in host-pathogen interactions. Most 
viruses encode a limited number of the proteins and the interactions among those proteins may 
help in performing multiple functions. The 100K protein acts as chaperon for trimerization of 
hexon protein in HAdV-5 and HAdV-2 infected cells (Oosterom-Dragon and Ginsberg 1981; 
Hong et al., 2005; Cepko and Sharp, 1982) and is involved in preventing apoptosis by granzyme 
B (Andrade et al., 2001) Here, we report the characterization of BAdV-100K protein and 
demonstrate that amino acid 624-637 involved in the interaction with 33K protein may be essential 
for the replication of BAdV-3. 
The BAdV-3 100K is predicted to encode 850 amino acids. Although a protein of 130 kDa 
could be detected at early (24 hrs) post infection, multiple bands could be detected at late times 
(36-48 hrs) post infection. It is possible that different forms of 100K protein could arise due to post 
translation modifications as observed in HAdV-5 infected cells (Xi et al., 2005; Koyuncu and 
Dobner, 2009). Alternatively, different forms of 100K could arise due to proteolytic cleavage. 
Although 100K protein is localized in the nucleus and cytoplasm of BAdV-3 infected cells, it is 
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predominantly localized in the cytoplasm of transfected cells. In contrast, localization of HAdV-5 
100K appears similar in infected/transfected cells (Koyuncu and Dobner, 2009). These results 
suggest that nuclear localization of BAdV-3 100K may require other viral or cellular proteins. 
An earlier report suggested that HAdV-2 100K interacts with hexon (Wodrich et al., 2003). 
Recently, we demonstrated that 33K protein interact with 100K protein in BAdV-3 infected cells 
(Kulshreshtha and Tikoo, 2008). However, co-expression of 100K protein with either hexon or 
33K proteins did not alter the cytoplasmic location of 100K in transfected cells. This is despite the 
fact that BAdV-3 100K contains a potential bipartite nuclear localization signal. It is possible that 
nuclear localization of BAdV-3 100K requires more than one viral/cellular protein. Alternatively, 
it is possible that nuclear localization of BAdV-3 100K in infected cells occurs due to yet 
unidentified cellular factor.  
Earlier, we demonstrated that amino acid 161-200 of 33K are involved in interacting with 
100K of BAdV-3 (Kulshrestha and Tikoo 2008). Using different assays including bio 
immunofluorescence molecular complementation assay, we reconfirmed these observations and 
further demonstrated that a stretch of amino acids 624-637 of 100K appears to be involved in the 
interaction with 33K. Although, precise location and functional importance of the interacting 
domain in the different steps of BAdV-3 replication is not known yet, it is noteworthy to suggest 
that 100K-33K interaction may have a role in the event occurring in the cytoplasm of infected 
cells. Moreover, amino acid 1-742 containing the interacting domain appear to be retained in the 
cytoplasm of cell (chapter 5). 
Like HAdV-2 (Xi et al., 2004), 100K protein appears to be essential for the replication of 
BAdV-3. The inability to isolate mutant BAdV-3 expressing 100K containing a deletion of 624-
637 amino acids suggests that the 100K-33K interaction is essential for BAdV-3 replication. 
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Alternatively, deletion of 14 amino acid interacting region of 100K may disrupt other unknown 
vital function. Although analysis of 14 amino acids did show the presence of a non-canonical class 
I SH3 ligand specific motif (DGQPTKP) (Dinkel et al., 2012), amino acid homology search 
reveled 30.77% identity in similar region among 100K proteins encoded by different 
Mastadenoviruses (HAdV-2 and HAdV-5). It would be interesting to determine the role of specific 
amino acids by constructing point mutants that prevent interaction and determine the importance 
of these in different steps of BAdV-3 life cycle. 
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4.0 INTERACTION OF BAdV-3 100K PROTEIN WITH CELLULAR PROTEIN Tctex-1 
4.1 Introduction 
 Adenoviruses are the large family of medium sized, non-enveloped, double stranded DNA 
viruses which can infect broad range of vertebrate hosts (Berk, 2007). Like other viruses, 
adenoviral proteins interact with the cellular proteins during the infection process of cells. Some 
of the adenoviral proteins and cellular proteins interactions include fiber knob domain and 
coxsackie and adenovirus receptor (Cupelli and Stehle, 2011; Arnberg. 2012), penton base and 
integrins (Wickham et al., 1993), hexon and dynein intermediate chain 2 C (Bremner et al., 2009), 
E1A protein and retinoblastoma (Rb) protein (Ghosh and Harter, 2003), E1B-55K protein and pro-
apoptotic activator protein p53 (Levine. 1997; White, 2001), E4orf6 and p73 (Steegenga et al., 
1999), 100K protein and translation initiation factor eIF4G (Cuesta et al., 2004), 100K protein and 
human protein arginine methyltransferase 1 (Kzhyshkowska et al., 2004) and 33K protein and 
presenilin-1-associated protein (PSAP) (Kulshreshtha, 2009). 
 Dynein and kinesin motors are responsible for cargo transport towards and away from 
microtubule-organizing center (MTOC) on the microtubules respectively (Dodding and Way, 
2011). Cytoplasmic dynein motors are high molecular weight (~1.5 mDa) complex comprising six 
subunits including heavy chains, intermediate chains, light intermediate chains and light chains 
(Pfister et al., 2005). There are six dynein light chains (10-14 kDa), which bind the various cargos 
designated as DYNLL1, DYNLL2, DYNLT1, DYNLT3, DYNLRB1 and DYNLRB2. Moreover, 
the dynein light chains DYNLT1 and DYNLT3 can form the homodimers and heterodimers (Lo 
et al., 2007b). Interestingly, only homodimers of the DYNLT1 and DYNLT3 can bind with the 
intermediate chain for transport (Lo et al., 2007b). DYNLT1 was also reported to interact with the 
other cellular proteins namely Doc2 (Nagano et al., 1998), neuronal voltage gated calcium 
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channels (Lai et al., 2005) and C-terminus of rhodopsin protein (Tai et al., 1999). DYNLT3 has 
been implicated to interact with the cellular protein Bub3 and have important role in mitosis 
progression (Lo et al., 2007a). DYNLRB1 was reported to interact with the cellular protein reduced 
folate carrier (Ashokkumar et al., 2009). DYNLRB2 was found to play a key role in the TGFbeta 
signaling through Smad3 (Jin et al., 2009). Dynein light chains DYNLL1 and DYNLL2 interact 
with the myosin-Va, an actin-based neuronal motor protein (Espindola et al., 2000). These 
observations point to additional roles of dynein light chains in transcription regulation (Crepieux 
et al., 1997).  
 Viruses use the cellular motors for the movement through the dense cytoplasm of infected 
cells (Lyman and Enquist, 2009). Both DNA (herpesvirus (Lyman and Enquist, 2009), adenovirus 
(Bremner et al., 2009), parvovirus (Suikkanen et al., 2003), baculovirus (Ohkawa et al., 2010)) 
and RNA (retrovirus (Lehmann et al., 2009)) viruses have been reported to utilize microtubule 
network for efficient infection. Although a number of proteins encoded by both DNA (VP26, VP5, 
US9) (Lyman and Enquist, 2009; Kratchmarov et al., 2013) and RNA (P protein, gag protein) 
(Raux et al., 2000; Petit et al., 2003) viruses have been reported to interact mainly with dynein 
light chains, the biological significance of only few has been explored. 
 A few adenovirus (AdV) proteins have been shown to interact with proteins of the 
microtubule network (Engelke et al., 2011). Interaction of viral structural proteins including 
adenovirus hexon with cytoplasmic dynein mediates transport of the virus across the cytoplasm of 
infected cells (Bremner et al., 2009). Interaction of AdV E3 nonstructural protein 19K with 
components of microtubules has been suggested to retain class I major histocompatibility complex 
molecules when complexed with gp19 into endoplasmic reticulum thus down regulating cell 
surface expression of MHC-1 proteins (Dahllof et al., 1991). Another adenovirus E3 encoded non-
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structural protein 14.7K has been reported to interact with dynein (Lukashok et al., 2000). 
Although biological significance of 14.7K-dynein interaction is not clear, the potential of its role 
in viral spread has been proposed. Here, we report the interaction of BAdV-3 100K protein of with 
the dynein light chain protein DYNLT1 using the yeast two-hybrid, coimmunoprecipitation and 
GST pull-down assays. 
 Dyneins are cytoplasmic molecular motors responsible for the transport of cargo towards the 
negative end of microtubule (Lo et al., 2007b). The cytoplasmic dynein light chains have been 
divided into three main types DYNLT, DYNLRB and DYNLL, each with two isoforms (Pfister et 
al., 2005). Dynein light chains are link between the cargo proteins and dynein light intermediate 
chains. Many viral and cellular proteins have been found to bind the dynein light chains for the 
transport in the dense cytoplasmic environment. The dynein light chain protein was of Culex 
quinquefasciatus, which has the amino acid sequence similarity with the DYNLT1 protein of Bos 
taurus. 
4.2 Materials and methods 
4.2.1 Cell lines and viruses 
 Madin-Darby bovine kidney (MDBK) cells were propagated in the minimum essential 
medium (MEM) (HyClone® Laboratories, Inc., SH30024.01) supplemented with 10 % fetal 
bovine serum (FBS) (PAA Laboratories Inc., A15-203). 293T (a human embryonic kidney) cells 
and Vero cells were cultured in the Dulbecco's modified Eagle medium (DMEM) (HyClone® 
Laboratories, Inc., SH30022.01) supplemented with 10 % FBS. The wild-type BAdV-3 (WBR-1 
strain) was propagated as described earlier (Reddy et al., 1998). 
 65 
4.2.2 Plasmids 
 The construction of plasmid pcDNA.b100K, pGBKT7.b100K, pGADT7.b100K, pcDNA 
b100K(121-163d)c1, pcDNA.b100K(234-280d)c2, pcDNA.b100K(338-370d)c3, and 
pcDNA.b100K(463-497d)c4 has been described (section 3.2.4). Plasmids pGEX-DYNLT1, 
pGEX-DYNLT3 and pLexA-LC8 expressing the DYNLT1, DYNLT3 and DYNLL1 were a 
generous gift from Dr. Russells Diefenbach (Westmead Millennium Institute, Australia) (Douglas 
et al., 2004). All the cloning reactions were performed by the standard molecular techniques. 
(a) pGBKT7.DYNLT1. A 339 bp DNA fragment containing DYNLT1 ORF was amplified by PCR 
using primers GBKDYNLT1·F and GBKDYNLT1·R (Table 4.1), and plasmid pGEX-
DYNLT1 (Douglas et al., 2004) DNA as template. The PCR product was digested by EcoRI-
NotI and ligated to EcoRI-NotI digested plasmid pGBKT7 (Clontech, 630489) downstream of 
DNA binding domain of Gal4 gene creating plasmid pGBKT7.DYNLT1. 
(b) pGADT7.DYNLT1. A 339 bp DNA fragment containing DYNLT1 ORF was amplified by PCR 
using primers GADDYNLT1·F and GADDYNLT1·R (Table 4.1), and plasmid pGEX-
DYNLT1 (Douglas et al., 2004) DNA as template. The PCR product was digested by EcoRI-
XhoI and ligated to EcoRI-XhoI digested plasmid pGADT7 (Clontech, 630489) downstream 
of DNA activation domain of Gal4 gene creating plasmid pGADT7.DYNLT1. 
(c) pGBKT7.DYNLT3. A 348 bp DNA fragment containing DYNLT3 ORF was amplified by PCR 
using primers GBKDYNLT3 F and GBKDYNLT3 R (Table 4.1), and plasmid pGEX-
DYNLT3 (Douglas et al., 2004) DNA as template. The PCR product was digested by EcoRI-
NotI and ligated to EcoRI-NotI digested plasmid pGBKT7 (Clontech, 630489) downstream of 
DNA binding domain of Gal4 gene creating plasmid pGBKT7.DYNLT3. 
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(d) pGBKT7.b100K. Construction of plasmid pGBKT7.b100K is previously described (section 
3.2.4). 
(e) pGADT7.b100K. Construction of plasmid pGADT7.b100K is previously described (section 
3.2.4). 
(f) pGBKT7.DYNLL1. A 267 bp DNA fragment containing DYNLL1 ORF was amplified by PCR 
using primers GBKDYNLL1 F and GBKDYNLL1 R (Table 4.1), and plasmid pLexA-LC8 
(Douglas et al., 2004) DNA as template. The PCR product was digested by EcoRI-NotI and 
ligated to EcoRI-NotI digested plasmid pGBKT7 (Clontech, 630489) downstream of DNA 
binding domain of Gal4 gene creating plasmid pGBKT7.DYNLL1. 
(g) pb100K.EY. Construction of the 100K-EYFP gene fusion expressing plasmid is previously 
described (section 3.2.4). 
(h) pDR.DYNLT1. A 339 bp DNA fragment containing DYNLT1 ORF was amplified by PCR 
using primers DRDYNLT1·F and DRDYNLT1·R (Table 4.1), and plasmid 
pGADT7.DYNLT1 as template DNA. The PCR product was digested by BamHI-XbaI and 
ligated to BamHI-XbaI digested plasmid pDsRed-monomer C1 (Clontech, 632466) creating 
plasmid pDR.DYNLT1. 
(i) pcmyc.DYNLT1. A 339 bp DNA fragment containing DYNLT1 ORF was amplified by PCR 
using primers cmycDYNLT1·F and cmycDYNLT1·R (Table 4.1), and plasmid 
pGADT7.DYNLT1 as template DNA. The PCR product was digested by EcoRI-XhoI and 
ligated to EcoRI-XhoI digested plasmid pc.cmyc creating plasmid pcmyc.DYNLT1. 
(j) pcDNA.b100K(1-498). A 1494 bp DNA fragment encoding the N-terminus 498 amino acids 
of 100K gene was PCR amplified using the primers b100K·F and b100K(1-498) R (Table 4.1), 
and plasmid pcDNA.b100K (section 3.2.4) DNA as a template. The amplified PCR product 
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was digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(1-498).  
(k) pcDNA.b100K(1-588). A 1764 bp DNA fragment encoding the N-terminus 588 amino acids 
of 100K gene was PCR amplified using the primers b100K·F and b100K(1-588) R (Table 4.1), 
and plasmid pcDNA.b100K (section 3.2.4) DNA as a template. The amplified PCR product 
was digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(1-588). 
(l) pcDNA.b100K(499-587d). A 1530 bp fragment of 100K gene was amplified by PCR using the 
primers b100K·F and b100K(499-587d)·R (Table 4.1), and plasmid pcDNA.b100K DNA as a 
template. Secondly, a 819 bp fragment of 100K gene was amplified by PCR using the primers 
b100K(499-587d)·F and b100K·R (Table 4.1), and plasmid pcDNA.b100K DNA as a 
template. The third PCR was performed using the primers b100K·F and b100K·R (Table 3.1) 
and both previously amplified annealed PCR products as a template. The PCR product was 
digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid pcDNA3.1(+) 
creating plasmid pcDNA.b100K(499-587d). 
(m) pGN.100K. Construction of the plasmid pGN.100K is previously described (section 3.2.4). 
(n) pGN.100K(499-587d). A 2280 bp DNA fragment containing 100K (499-587 amino acid 
deletion) ORF was amplified by PCR using the primers GN·100K·F and GN·100K·R (Table 
4.1), and plasmid pcDNA.b100K DNA as a template. The PCR amplified product was digested 
with XmaI-EcoRI and ligated to XmaI-EcoRI digested plasmid pGN (Levin et al., 2009) 
creating plasmid pGN.100K(499-587d). 
(o) pGC.DYNLT1. A 339 bp DNA fragment containing DYNLT1 ORF was amplified by PCR 
using primers GC DYNLT1·F and GC DYNLT1·R (Table 4.1), and plasmid pGADT7. 
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Table 4.1 List of oligonucleotides 
Oligo name Sequence (5′-3′)a 
GBKDYNLT1·F GAGGCCGAATTCATGGAAGACTACCAGGCTGC 
GBKDYNLT1·R AGTTATGCGGCCGCTGCAGGTCGAGTCAAATAGAGAGTCCGAAGG 
GADDYNLT1·F GCCAGTGAATTCATGGAAGACTACCAGGCTGC 
GADDYNLT1·R CTGCAGCTCGAGTCAAATAGAGAGTCCGAAGG 
GBKDYNLT3·F GAGGCCGAATTCATGGAGGAGTACCATCGCCA 
GBKDYNLT3·R AGTTATGCGGCCGCTGCAGGTCGAGTTAAAGAACAATAGCAATGG 
GBKDYNLL1·F GAGGCCGAATTCATGTGCGACCGAAAGGCCGTG 
GBKDYNLL1·R AGTTATGCGGCCGCTTAACCAGATTTGAACAGAAG 
DRDYNLT1·F GGCCCGGGATCCCCGGGCGAATTCATGGAAGACTACCAGGCTGC 
DRDYNLT1·R CAGTTATCTAGATGCATGCTCGAGTCAAATAGAGAGTCCGAAGG 
cmycDYNLT1·F CCGGGCGAATTCATGGAAGACTACCAGGCTGC 
cmycDYNLT1·R TGCATGCTCGAGTCAAATAGAGAGTCCGAAGG 
b100K·F AGACCCAAGCTTATGGCAGAGAAAGGCAGTGAAAATC 
b100K(1-498)·R TATACCTCTAGACTATAGGTCTTGAGCTATGGTG 
b100K(1-588)·R TATACCTCTAGACTAGATGTCGGAGTGAAACATGAG 
b100K(499-587d)·F ACCATAGCTCAAGACCTAGGTCTCATGGAATGCTACTGTCGC 
b100K(499-587d)·R GCGACAGTAGCATTCCATGAGACCTAGGTCTTGAGCTATGGT 
b100EY·R GTGGCGACCGGTCTCTTCTTGCCCTGGCCCTTC 
GN·100K·F TGTCGCCCCGGGATGGCAGAGAAAGGCAGTGAAAATCAGC 
GN·100K·R AAAGCTGAATTCCTACTCTTCTTGCCCTGGCCCTTC 
GC DYNLT1·F GTCGACCCCGGGATGGAAGACTACCAGGCTGCGGAGG 
GC DYNLT1·R AAAGGCCGCGGCCGCTCAAATAGAGAGTCCGAAGGCAC 
a Restriction enzyme sites are underlined. 
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DYNLT1 as template DNA. DNA as a template. The PCR amplified product was digested with 
XmaI-NotI and ligated to XmaI-NotI digested plasmid pGC (Levin et al., 2009) creating plasmid 
pGC.DYNLT1. 
4.2.3 Transfections 
 Vero or 293T cells at the 70% confluency were transfected with plasmid DNA (2 μg/2 x 105 
cells) using the LipofectamineTM 2000 (Life Technologies, 11668-019) transfection reagent as per 
the manufacturer’s protocol. At 48 h post-transfection, the cells were lysed for the analysis of 
protein expression by Western blot or fixed for analysis of protein expression of by 
immunofluorescence. 
4.2.4 Western blot analysis 
 MDBK cells at 75% confluency were infected with wild-type BAdV-3 at an MOI of 5. At 
indicated times post-infection, the cells were collected and lysed with 1 mL of 
radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1% NP-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris (pH 8)) with protease inhibitors 
(aprotinine, leupeptin, pepstatin A 1 μg/mL each). Proteins from the lysates were separated by 
10% SDS PAGE, transferred to the nitrocellulose membrane (Bio-Rad, 162-0115) and probed in 
Western blot using protein specific antibodies as described (section 3.2.7). 
4.2.5 Yeast two-hybrid system 
 Yeast two-hybrid assay was performed according to the supplier’s instruction manual 
(Clontech, PT3247-1) as described (section 3.2.8). 
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4.2.6 GST pull-down assay 
The assay was performed as described (section 3.2.9) using purified GST, GST-DYNLT1 
fusion protein and [35S] labeled in vitro transcribed/translated proteins. 
4.2.7 Bimolecular fluorescence complementation assay 
 The assay was performed as described previously (Levin et al., 2009) with minor 
modifications (section 3.2.10). 
4.2.8 Immunoprecipitation/Western blot  
 293T cells seeded in 60 mm tissue culture plates (Nunc®) were co-transfected with plasmid 
DNA pcDNA.b100K and pcmyc.DYNLT1 (4 µg each) using the Lipofectamine 2000 reagent (as 
described in section 4.2.3). At 48 h post-transfection the cells were collected, lysed and 
immunoprecipitated using anti-100K (N100, C100 or both) sera. The immunoprecipitated proteins 
were fractionated by 10% SDS-PAGE, transferred to the nitrocellulose membrane (Bio-Rad) and 
probed in Western blot using monoclonal anti-DYNLT1 (Sigma, D9944). 
4.2.9 Immunofluorescence microscopy 
 MDBK cells were infected with wild type BAdV-3 at 0.5 MOI on 4 well coverslip and 
processed at 48 h after infection as follows. Similarly transfected Vero cells were also processed 
at 48 h posttransfection. Cells were fixed in 4% paraformaldehyde in PBS for 30 minutes at room 
temperature, and permeabilized by 0.5% Triton X-100 in PBS for 15 minutes. Cells were stained 
with primary antibody against 100K and counter stained with Cy2 AffiniPure Goat Anti-Rabbit 
IgG (Jackson ImmunoResearch Laboratories, Cat. No.: 111-225-003). Cells were washed in PBS 
for three times each of 10 minutes and later counter stained with 4',6-diamidino-2-phenylindole 
(DAPI) followed by three more washes. Later, the coverslips were mounted with Citifluor AF4 
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mounting media. Images were captured using the different laser lines under laser scanning 
confocal microscope (Zeiss LSM410). 
4.2.10 LC-MS/MS 
 MDBK cells infected with wild-type BAdV-3 at an MOI of 5 were harvested at 48 h 
postinfection (p.i.). The cells were lysed with RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris (pH 8)) and incubated with   
anti-100K (N100 and C100 mix) sera coupled to protein A agarose beads were added to the mixture 
and incubated further at 4 °C for 4 h. After extensive washing, the beads were mixed with 2X SDS-
sample buffer, boiled for 2 min, and proteins were separated by 10 % SDS-PAGE. After 
electrophoresis, the gel was stained with Coomassie Blue R-250 (Sigma). Bands of interest were 
excised from the SDS gel and sent for liquid chromatography-mass spectrometry (LC-MS/MS) for 
identifying proteins. Mass spectrometry analysis was performed at the Plant Biotechnology 
Institute (Saskatoon, Canada) using the robotic workflow of tryptic digestion and chromatography 
in G-ToF Ultima Mass Spectrometer (Micromass, UK). 
4.2.11 Data analysis 
 Peptides generated by the mass spectrometric analysis of the sample were subjected to NCBI 
nr database search for the identification of suspected interacting proteins. The database search 
algorithm programme Mascot from Matrix Science was used to for protein identification. The 
proteins hits with the scores of above 60 were considered for the current analysis. 
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4.3 Results 
4.3.1 Mass spectrometric identification of cellular proteins interacting with 100K protein of 
BAdV-3 
 Protein-protein interactions play an important role in the host-pathogen interaction. In order 
to identify the cellular proteins interacting with 100K protein during the BAdV-3 infection of 
MDBK cells, co-immunoprecipation assay using anti-100K (N100 and C100 mix) sera coupled 
with mass spectrometry analysis was performed. The Mascot search parameter was set to generate 
the result with p value at <0.05 level of significance. Individual Mascot score above 35 indicated 
identity or extensive homology. Proteins with two or more peptides identified were considered 
positive. The search results were manually curated to remove the immunoglobulin chains of 
Oryctolagus cuniculus due to the use of anti-sera raised in rabbit. The LC-MS/MS analysis 
identified six putative cellular proteins potentially interacting with 100K in BAdV-3 infected cells 
(Table 4.1). 
 Since structure and function of dynein light chain particularly in successful virus infections 
is well documented (Bremner et al., 2009; Lehmann et al., 2009; Lyman and Enquist, 2009), we 
direct our efforts to the study the interaction of dynein light chain proteins with BAdV-3 100K 
protein.  
4.3.2 Interaction of 100K and DYNLT1 proteins in vitro 
 To verify the results of mass spectrometric analysis and identify the type of dynein light 
chain interacting with BAdV-3 100K protein, initially yeast two hybrid analysis was performed. 
Plasmids expressing the DYNLT1 (pGBKT7.DYNLT1), DYNLT3 (pGBKT7.DYNLT3) or 
DYNLL1 protein (pGBKT7.DYNLL1) fused to binding domain of yeast GAL4 were individually 
transformed into yeast (Saccharomyces cerevisiae) cell AH109 with the plasmid pGADT7.100K  
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Table 4.2 List of novel suspected protein partners of 100K protein during BAdV-3 infection 
by LC-MS 
Suspected protein partner of 100K 
Mascot 
score 
Queries matched 
Multi-sensor signal transduction histidine kinase 68 15 
Chaperone protein DnaK 67 10 
Putative TRAP-type C4-dicarboxylate transport system 63 9 
Transcription elongation factor NusA 63 8 
ABC transporter, ATPase subunit 62 9 
Dynein light chain 67 7 
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encoding BAdV-3 100K protein fused to DNA activation domain of yeast GAL4. The mixture was 
plated on the agar plates with selective dropout media. No autoactivation of the reporter genes was 
observed when individual plasmid DNA was transformed into yeast AH109. All the three co-
transformants showed growth on –leucine and –tryptophan plate after 5 days of incubation at 30 
°C in humidified chamber (data not shown). There was no growth on the –leucine, –tryptophan 
and –histidine plates in the cotransformants expressing BAdV-100K fusions and fusion of 
DYNLT3 or DYNLL1 proteins (data not shown). However, cotransformants expressing DYNLT1 
fusion and BAdV-3 100K fusion showed the growth and blue color development on the –leucine, 
–tryptophan, –histidine, –adenine plates supplemented with the X-alpha-gal (Figure 4.1). These 
results validated the findings of mass spectrometry analysis and identified the cellular protein 
DYNLT1 as the interactor of 100K protein of BAdV-3. The interaction between p53 and large T 
antigen served as positive control for the experiment. The plasmid DNA pair of pGBKT-Lam and 
pGADT-T served as negative control for the experimental procedure. Similar results were 
observed using reverse yeast two-hybrid analysis (data not shown). 
4.3.3 Interaction of 100K and DYNLT1 in vivo 
 The yeast two-hybrid results were validated by coimmunoprecipitation assay. Plasmid 
pcmyc.DYNLT1 (expressing N-terminus cmyc epitope tagged DYNLT1 fusion protein) DNA and 
pcDNA.b100K (expressing the BAdV-3 100K protein) were cotransfected into the 293T cells. At, 
48 hours post-transfection, proteins from the lysates of the cells were immunoprecipitated with 
anti-100K (N100 and C100 mix) sera. The immunoiprecipitated proteins were separated by 10 % 
SDS-PAGE and probed in Western blot using anti-DYNLT1 MAb. As seen in figure 4.2, two 
proteins of 12.5 and 14 kDa were observed when proteins from transfected (pcDNA.b100K + 
pcmyc.DYNLT1) cells were immunoprecipitated with anti-100K (N100 + C100) antibody and  
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Figure 4.1 Yeast two-hybrid analysis of 100K protein interaction with the dynein light chains. 
The yeast cells (AH109) were transformed with the bait and prey plasmids (mentioned on the right 
side of each photograph) and plated on the –leucine, –tryptophan, –histidine, –adenine plates 
supplemented with the X-alpha-gal. Plates were incubated at 30 °C for a week and observed for 
the growth and color development. Plasmid pGBKT7.p53 and pGADT7.T were used as positive 
controls for the assay.  
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probed in Western blot with anti-DYNLT1 MAb. No such bands were detected when transfected 
(pcDNA.b100K+pcmyc.Tctex-1) cells were immunoprecipiated with normal rabbit IgG and 
probed in Western blot with anti-DYNLT1 antibody. As expected 12.5 kDa protein was detected 
when transfected cells (pDNA.b100K+pc.myc) were immunoprecipitated with anti-100K (N100 
and C100 mix) sera and probed in Western blot using anti-DYNLT1 antibody. No such protein 
was detected when transfected cells (pDNA.b100K+pc.myc) were immunoprecipiated with 
normal rabbit IgG and probed in Western blot with anti-DYNLT1 antibody. 
4.3.4 Co-localization of 100K protein and DYNLT1 protein 
 The interaction of 100K protein with the cellular protein DYNLT1 was confirmed by yeast 
two-hybrid and coimmunoprecipitation assay prompted to probe for the subcellular distribution of 
100K and DYNLT1 in the cotransfected cells. Cellular protein DYNLT1 localized to the 
cytoplasm and nucleus of the transfected cells (Sachdev et al., 2007). BAdV-3 100K protein 
localized to the cytoplasm of transfected cells (Fig. 4.3). 
4.3.5 Identification of region of 100K protein interacting with DYNLT1 protein 
 To characterize the interaction of the 100K protein of BAdV-3 with cellular protein 
DYNLT1 an attempt was made to identify the interacting domain of 100K protein. GST pull-down 
assay was employed for identification of domain of 100K protein interacting with DYNLT1. 
Initially, four coiled coil regions (121-163aa, 234-280aa, 338-370aa, 463-497aa) were identified 
in the 100K protein sequence using the COILS server (Lupas et al., 1991). Individual coiled coil 
region deletions of 100K gene were created in the pcDNA3.100K plasmid background using the 
standard molecular cloning techniques. The wild type and coiled coil deletions of 100K gene were 
in vitro transcribed and translated in the presence of radiolabelled methionine [35S] and incubated 
with the GST alone or GST-DYNLT1 in the presence of the glutathione sepharose beads. All the  
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Figure 4.2 Co-immunoprecipitation of 100K and DYNLT1 proteins. Proteins from the lysates 
of 293T cells transfected with the indicated plasmids DNAs were immunoprecipitated with the 
anti-100K serum (N100 and C100 mix) or the pre-bleed rabbit serum (IgG). Separated by 15 % 
SDS-PAGE and transferred to nitrocellulose membranes. Immunoblotting was performed using 
the anti-DYNLT1 MAb and the alkaline phosphate conjugated anti-mouse secondary antibody. 
Position of molecular weight marker (kDa) is indicated on the left of the panel. Arrows on the right 
of panel indicates the detected proteins. 
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Figure 4.3 Subcellular distribution of 100K protein of BAdV-3 and dynein light chain 
DYNLT1 protein in cotransfected cells. (A) Schematic representation of the plasmid DNA. The 
name of the plasmid is depicted on the right of the panel. The name of the protein is depicted on 
the left of the panel. (B) Vero cells were co-transfected with the plasmid DNA encoding EYFP-
100K and cmyc-DYNLT1 fusion proteins. At 48 hrs post transfection, the localization of protein 
was visualized by direct fluorescence (panel a) or indirect fluorescence (panel b) using the anti-
cymc MAb. Nuclei were stained with DAPI (panel c). A merge (panel d) of the images is shown. 
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interaction and absence of role of any coiled coil regions of 100K protein in mediating the 
interaction with the cellular protein DYNLT1. Interestingly, there was presence of double bands 
for the in vitro translated and transcribed product of 100K protein, which may be due to 
posttranslational modifications. 
 Next, the GST pull-down assay was performed with a series of sequential 100K gene 
deletions from C-terminus. The result suggested amino acids 498-588 of 100K protein are 
responsible for the interaction with the DYNLT1 protein (Figure 4.5). There was no pull-down of 
any of the 100K wild-type or deletion proteins with the GST protein alone, implying the specificity 
of the interaction. The 100K protein interaction with DYNLT1 was confirmed by BiFC assay. 
There was no green fluorescence visible in the yeast cells transformed with the vectors or 
interacting region deleted plasmid DNA (Figure 4.6). 
4.4 Discussion 
 Protein-protein interactions between host and pathogen are an important event in the life 
cycle of viruses. Earlier, a number of adenovirus early proteins and late structural proteins have 
been reported to interact with different cellular proteins (Wickham et al., 1993; White, 2001; Berk, 
2005; Bremner et al., 2009; Arnberg. 2012) and perform important biological functions. 
 AdV-100K, a late non-structural multifunctional protein has been reported to interact with 
eIF4G and enhance translation of late viral proteins in HAdV-5 (Tasseron-De Jong et al., 1979; 
Riley and Flint, 1993; Xi et al., 2005). AdV-100K is also reported to interact with Granzyme H 
and prevent it from interacting with granzyme B in HAdV-5 preventing apoptosis (Andrade et al., 
2001; Waterhouse and Trapani, 2007). Although some cellular factors interacting with 100K have 
been identified, the existence of additional cellular factors has not been ruled out. Since, 100K 
 80 
protein is not detected in the mature virion and identified only in the infected cell lysate (Anderson 
et al., 1973),  
 
 
Figure 4.4 Interaction of coiled coils domain deletions of 100K proteins with GST-DYNLT1 
protein. (A) Schematic representation of plasmid DNAs. The straight line represents BAdV-3 
100K DNA. The number above denotes amino acid position of 100K protein. The name of the 
protein is depicted on the left of the panel. (B) The in- vitro transcribed/translated radiolabelled 
indicated proteins were individually incubated with the purified GST alone or GST-33K fusion 
protein. The bound protein was separated by 10 % SDS PAGE and visualized by exposure to the 
phoshorimager screen. Input radiolabelled protein was 5% of the reaction volume. The molecular 
weights in kDa are indicated on the left side of the figure. The molecular weights in kDa are 
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indicated on the left of the panel; c1 [pcDNA b100K(121-163d)c1]; c2 [pcD NA.b100K(234-
280d)c2]; c3 [pcDNA.b100K(338-370d)c3]; c4 [pcDNA.b100K(463-497d) c4]. 
 
 
Figure 4.5 Identification of 100K protein region interacting with GST-DYNLT1 protein by 
GST pull-down assay. (A) Schematic representation of plasmid DNAs. The straight line 
represents BAdV-3 100K DNA. The number above denotes amino acid position of 100K protein. 
The name of the protein is depicted on the left of the panel. (B) The in vitro transcribed/translated 
radiolabelled indicated proteins were individually incubated with the purified GST alone or GST-
33K fusion protein. The bound protein was separated by 10 % SDS PAGE and visualized by 
exposure to the phoshorimager screen. Input radiolabelled protein was 5% of the reaction volume. 
The molecular weights in kDa are indicated on the left side of the figure; 498 [pcDNA b100K(1-
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498)]; 588 [pcDNA.b100K(1-588)]; (499-588d) [pcDNA.b100K (499-588d)]; 100K 
[pcDNA.b100K]. 
 
Figure 4.6 Bimolecular fluorescence complementation assay. Yeast cells were co-transformed 
with the indicated plasmid DNAs plated on the uracil and histidine deficient agar plates and grown 
at 30° C for 5 days and processed for confocal microscopy for the presence of the green 
fluorescence using Zeiss LSM 5 laser scanning confocal microscope. Empty vector pGN and pGC 
were used as negative controls for the self-complementation. 
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it may interact with the other cellular proteins during the infection process of adenovirus including 
BAdV-3. Here, we demonstrate that 100K interacts with dynein light chain DYNLT1. 
 Mass spectrometric analysis of coimmunoprecipitated protein complexes have been 
employed successfully for identifying the novel cellular proteins interacting with viral proteins 
(Katoh et al., 2011; Gorai et al., 2012; Shelton et al., 2012). We identified the six novel proteins 
namely (Table 4.2) coimmunoprecipitated with the 100K protein in BAdV-3 infected MDBK cells. 
Interestingly, we did not detect the cellular proteins (eIF4G, grazyme B) known to interact with 
AdV 100K (Andrade et al., 2003; Xi et al., 2004). This could be due to transient nature of the 
interactions, timing of collection of sample for immunoprecipitation or differences in 100K protein 
sequences encoded by Mastadenoviruses. 
 Dyneins are composed of four polypeptides (heavy chain, intermediate chain, intermediate 
light chain and light chain) and are divided into cytoplasmic dyneins or axonemal dyneoins. 
Cytoplasmic dyneins are molecular motors responsible for the transport of cargo towards the 
negative end of microtubule (Lo et al., 2007b). The light chain(s) of dynein attach cargo while 
heavy chain of dynein attached to microtubules help to walk and move cargo along microtubules. 
The cytoplasmic dynein light chains have been divided into three main types DYNLT, DYNLRB 
and DYNLL each with two isoforms (Pfister et al., 2005). The cytoplasmic dynein light chain 
DYNLT1 also known as mouse t-complex testis expressed (Tctex-1) (Lader et al., 1989) or 
TCTEL1 (Watanabe et al., 1996) is involved in binding (Chuang et al., 2005) with many viral 
proteins thus helping in transport of different viruses through cytoplasm (Douglas et al., 2004; 
Vlach et al., 2008; Muller et al., 2010; Schneider et al., 2011). 
 Since many cellular and viral proteins are found to interact with the dynein protein(s), here 
we focused on the interaction of 100K with dynein proteins. Since human and bovine DYNLT1 
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proteins shared 100% identity at amino acid sequence level (data not shown), we used DYNLT1 
ORF expressing human DYNLT1 protein. The identified interaction of BAdV-3 100K and 
DYNLT1 was confirmed by GST-pull down assay. Moreover, co-immunoprecipitation assay 
confirmed that 100K protein interacted with cellular or plasmid derived and DYNLT11 in 
transfected cells and co-immunioprecipitation assay. However, initial attempts to detect co-
immunoprecipitated DYNLT1 from BAdV-3 infected MDBK cell lysates by Western blot were 
not successful. Since initial interaction of 100K and DYNLT1 was detected in BAdV-3 infected 
cells by co-immunoprecipitation/mass spectrometry, it is possible that 100K-DYNLT1 interaction 
is weak/transient and could not be detected in co-immunoprecipitated proteins from of BAdV-3 
infected cell lysates by Western blot analysis. 
 Although sequence motifs V-S-[K/H]-[T/S]-x-[V/T]-[T/S]-[N/Q]-V (Sugai et al., 2003) and 
[R/K]-[R/K]-x-x-[R/K] (Mok et al., 2001) in proteins have been reported to be involved in binding 
to DYNLT1, no  consensus motif required for binding to dynein light chain DYNLT1 has been 
established. Analysis of BAdV-3 100K protein sequence identified DYNLT1 binding motif [R/K]-
[R/K]-x-x-[R/K] (Mok et al., 2001) located at amino acid 775-779. However, deletion of amino 
acid 775-779 did not abolish the binding of BAdV-3 100K to DYNLT1 in GST-pull down assay. 
Secondly, analysis of BAdV-3 100K protein also identified 4 coiled-coil regions, which have been 
reported to interact with other proteins (Iacovides et al., 2007). However deletion of each coil-coil 
region did not alter the binding of BAdV-3 100K to DYNLT1 in GST-pull down assay. 
Interestingly, analysis of deletions/truncations of 100K protein suggested that amino acid 499-587 
of 100K contain the potential DYNLT1 binding region(s). 
 However, precise location of the DYNLT1 binding region could not be established using 
additional deletions/ truncation in GST-pull down assay. It is possible that the induced alterations 
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alter the extended β-strand conformation of 100K required for DYNLT1binding (Merino-Gracia 
et al., 2011). Alternatively, it is possible that multiple domains located between amino acid 499-
587 are involved in binding to DYNLT1, which may be disrupted by deletions/truncations. 
Interestingly, three domains have been identified in VP26 protein of herpes simplex virus (HSV)-
1, which are required for interaction with DYNLT1 (Apcarian et al., 2010).  
 Although many viral proteins bind dynein light chain (Merino-Gracia et al., 2011) for 
transport in the dense cytoplasmic environment, interaction of viral protein with dynein light chain 
also has been reported to be crucial for the activity of rabies viral polymerase and intracellular 
transport of rabies virus (Tan et al., 2007). Since BAdV-3 100K protein is a nonstructural protein, 
it is evident that interaction of BAdV-3 100K with DYNLT1 would not be involved in transporting 
BAdV-3 through cytoplasm during initial stage(s) of virus infection. An earlier report 
demonstrated the interaction of adenovirus E3 encoded non-structural protein 14.7K with 
DYNLT1, which may be involved in transport of 14.7K to the site of action (Lukashok et al., 
2000). Another report suggested that interaction of E3 non-structural protein 19K with 
microtubules components may alter the transport of class I major histocompatibility from 
endoplasmic reticulum to cell surface (Dahllof et al., 1991). It is possible that interaction of 100K 
with DYNLT1 may be involved in cytoplasmic transport and retention of 100K in the cytoplasm 
for performing some biological function. 
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5.0 CLEAVAGE OF BOVINE ADENOVIRUS-3 NON STRUCTURAL 100K PROTEIN IN 
INFECTED CELLS 
5.1 INTRODUCTION  
Assembly of progeny adenovirus particles occurs in the nucleus and involves both 
adenovirus DNA and proteins (Berk, 2007). Although mature adenovirus virions contain only 
structural proteins, the production of infectious adenovirus virions also requires the involvement 
of a number of non-structural proteins. Three nonstructural proteins 33K, 22K and 100K encoded 
by late L4 region of HAdV-5 are involved in different steps of adenovirus replication. Of these, 
the 100K protein has been shown to be involved in inhibition of host cell protein synthesis (Cuesta 
et al., 2000), enhancing selective translation of adenovirus late mRNAs (Xi et al., 2004) and 
preventing apoptosis by inhibiting the activity of granzyme B (Andrade et al., 2001). Moreover, 
100K mediates the trimerization and transport of hexon (Hong et al., 2005) for capsid assembly in 
the nucleus. 
Like other viruses (Kohl et al., 1988; Chambers et al., 1990; Gao et al., 1994), production of 
infectious progeny adenovirus includes a final maturation step involving the cleavage of proteins 
in assembled capsid by adenovirus protease (Weber, 1995; Mangel et al., 2003). Usually, the 
inactive form of protease present in immature virions is activated (by viral DNA and pVIc) and 
cleaves selected virion proteins present in assembled virions leading to the production of infectious 
progeny virions (Weber, 1976). Mature virions devoid of protease contain DNA but are non-
infectious as they unable to penetrate into the cell cytoplasm from the endosome (Greber et al., 
1996). Synthesis of an inactive form of adenovirus protease appears to be necessary for avoiding 
cleavage of precursor proteins before their assembly in virions (Ruzindana-Umunyana et al., 2000; 
Mangel et al., 2003), thus avoiding abortive infection. 
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Bovine adenovirus (BAdV)-3 is a non-enveloped icosahedral virion with a linear double 
stranded viral genome of 34446 bp (Reddy et al., 1998). Analysis of genome sequence and 
transcriptional map suggest that like human adenovirus (HAdV)-5 (Berk, 2007), BAdV-3 genome 
is also organized into early, intermediate and late regions. Although genome organization appears 
similar to HAdV-5, recent studies have identified features distinct to BAdV-3 including 
organization of late region gene families. A homolog of 100K is also encoded by BAdV-3, which 
is co-linear with 100K of HAdV-5 and shows 28.3 to 52.1 % identity with 100K proteins of other 
Mastadenoviruses (Reddy et al., 1998). Although cleavage of HAdV-5 100K, a non-structural 
protein by viral protease has been demonstrated in vitro, adenovirus protease specific cleavage of 
non-structural proteins has not been reported in virus infected/gene transfected cells (Ruzindana-
Umunyana et al., 2002). Here, we demonstrate that BAdV-3 100K is cleaved by adenovirus 
protease in gene transfected/virus infected cells, which does not appear to be essential for BAdV-
3 replication. 
5.2 MATERIALS AND METHODS 
5.2.1 Antibodies 
Production of anti-100K (N100 and C100) serum is described in chapter 3.2.2. Production 
of anti-33K sera (Kulshresthat et al., 2004) and anti-DBP (DNA binding protein) sera (Zhou et al., 
2001) has been described. Anti-HA monoclonal antibody (Sigma, H96580), anti-GFP antibody 
(Sigma, G6539), Cy3 conjugated affinipure goat anti-rabbit IgG (Jackson ImmunoResearch 
Laboratories, 111-165-003), Cy3 conjugated affinipure goat anti-mouse IgG (Jackson 
ImmunoResearch Laboratories, 115-165-003), Cy2 conjugated affinipure goat anti-mouse IgG 
(Jackson ImmunoResearch Laboratories, 115-225-003) were purchased and used as per 
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manufacturer’s instructions. Monoclonal anti-DYNLT1 antibody was procured from Sigma 
(D9944). 
5.2.2 Cell lines and Viruses 
Madin-Darby bovine kidney (MDBK) cells and CRL (cotton rat lung) cells were grown in 
the minimum essential medium (MEM) (HyClone® Laboratories, Inc., SH30024.01) 
supplemented with 10 % heat-inactivated gamma irradiated fetal bovine serum (FBS). Vero and 
293T cells were propagated in the DMEM supplemented with 10 % FBS, 10 mM HEPES buffer, 
0.1 mM NEAA and 50 μg/ml gentamycin. VIDO DT1 (cotton rat lung cells expressing I-SceI 
protein) cells were propagated in MEM supplemented with 10 % FBS and 50 μg/ml hygromycin 
B (Clontech Laboratories, Inc., 631309) (Du and Tikoo, 2010). The wild-type and mutant BAdV-
3s were propagated and titrated in MDBK cells (Reddy et al., 1998; Kulshreshtha et al., 2004). 
5.2.3 Plasmid construction 
Construction of plasmids pC.52K (Paterson et al., 2012) and pDR.Nucleolin (Corredor and 
Archambault, 2009) has been described. The plasmids were constructed using standard 
procedures. All plasmid constructions were verified by restriction enzyme analysis and DNA 
sequencing. Details of specific cloning procedures are as follows:  
a) Construction of plasmids expressing 100K protein 
i) pcDNA.b100K. A 2577 bp DNA fragment amplified by PCR using the primers b100K·F and 
b100K·R (Table 5.1), and plasmid pFBAV302 (Zakhartchouk et al., 1998) DNA as a template. 
The PCR product was digested with HindIII-XbaI and ligated to HindIII-XbaI digested plasmid 
pcDNA3.1(+) (Invitrogen, V790-20) creating plasmid pcDNA.b100K. 
ii) pHA.b100K. Two complementary oligonucleotides (HA·Link1 and HA·Link2, Table 5.1) 
designed to code for the HA epitope with four base overhangs compatible with HindIII were 
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annealed to create the linker. HA epitope ecoding linker was ligated to HindIII digested 
plasmid pcDNA.b100K creating plasmid pHA.b100K. 
iii) pb100K.EY. A 2580 bp DNA fragment amplified by PCR using primers b100EY·F and 
b100EY·R (Table 5.1), and plasmid pFBAV304 DNA as a template (Zakhartchouk et al., 
1998). The PCR product was digested with HindIII-AgeI and ligated to HindIII-AgeI digested 
plasmid pEYFP-N1 (Clontech) creating plasmid pb100K.EY. 
iv)  pHA.b100K.myc.EY. A 2636 bp DNA fragment amplified by PCR using primers 
B100K·EcoRI·F and B100K·BamHI·R (Table 5.1) and plasmid pFBAV302 (Zakhartchouk et 
al., 1998). DNA as template. The PCR product was was digested with EcoRI-BamHI and 
ligated to EcoRI-BamHI digested plasmid pEYFP-N1 (Clontech, 6006-1) creating plasmid 
pHA.b100K.myc.EY. 
v) pHA.h100K.myc.EY. A2507 bp DNA fragment amplified by PCR using primers 
H100K·EcoRI·F and H100K·BamHI·R (Table 5.1), and plasmid pHR-5 (Lobanova et al., 
2010). DNA as template was digested with EcoRI-BamHI and ligated to EcoRI-BamHI 
digested plasmid pEYFP-N1 (Clontech, 6006-1) creating plasmid pHA.h100K.myc.EY. 
Plasmid pHA.p100K.myc.EY. A 2600 bp DNA fragment amplified by PCR using primers 
P100K·EcoRI·F and P100K·BamHI·R (Table 5.1), and plasmid pFPAV200 (Reddy et al., 
1999). DNA as a template DNA was digested with EcoRI-BamHI and ligated to EcoRI-BamHI 
digested plasmid pEYFP-N1 (Clontech, 6006-1) creating plasmid pHA.p100K.myc.EY. 
b) Construction of plasmids expressing BAdV-3 proteins 
i) Plasmid pDR.pX. A 269 bp DNA fragment amplified by PCR using primers DRpX·XhoI·F 
and DRpX·EcoRI·R primers (Table 5.1), and plasmid pFBAV302 (Zakhartchouk et al., 1998).  
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Table 5.1 List of oligonucleotides 
Oligo name Sequence (5’-3’)a 
b100K·F AGACCCAAGCTTATGGCAGAGAAAGGCAGTGAAAATC 
b100K·R GGGCCCTCTAGACTACTCTTCTTGCCCTGGCC 
HA·Link1 
AGCTGAATTCGCCGCCATGGATTACCCATACGACGTACCAGATTA
CGCTA 
HA·Link2 
AGCTTAGCGTAATCTGGTACGTCGTATGGGTAATCCATGGCGGCG
AATTC 
b100EY·F GAGCTCAAGCTTATGGCAGAGAAAGGCAGTGAAAATC 
b100EY·R GTGGCGACCGGTCTCTTCTTGCCCTGGCCCTTC 
pVIII·EY·F CATATGAGCAAAGAAATTCCCACACCTTATGTTTGGACC 
pVIII·EY·R ACTGCAGAATTCCGCTATAACCGCTCACAGAGTTGC 
DRpX·XhoI·F ACTGACCTCGAGCTATGAGTCCCCGCGGAAATCTGAC 
DRpX·EcoRI·R ACTGACGAATTCCTATTTGTTGTGGGCCGCCTGAATG 
DRHx·XhoI·F GACGCCCTCGAGTTATGGTCCTACTGCACATCGCC 
DRHx·EcoRI·R TTGTTGGAATTCTTATGTGGTAGCGTTGCCGGCTGAG 
B100K·EcoRI·F 
AGCTTCGAATTCATGGATTACCCATATGACGTACCAGATTACATG
GCAGAGAAAGGCAGTG 
B100K·BamHI·R 
ACCGGTGGATCCTTCAGATCTTCCTCTGAGATGAGCTTTTGCTCCT
CTTCTTGCCCTGGCCCTTC 
H100K·EcoRI·F 
ACTGACGAATTCATGGATTACCCATATGACGTACCAGATTACATG
GAGTCAGTCGAGAAG 
H100K·BamHI·R 
ACTGACGGATCCTTCAGATCTTCCTCTGAGATGAGCTTTTGCTCCG
GTTGGGTCGGCGAACG 
P100K·EcoRI·F 
ACTGACGAATTCATGGATTACCCATATGACGTACCAGATTACATG
GAAGACCAGCACAGCGC 
P100K·BamHI·R 
ACTGACGGATCCTTCAGATCTTCCTCTGAGATGAGCTTTTGCTCCG
AGCCTCGCTGGGGACGAC 
BProt·XhoI·F ACTGACCTCGAGCTATGGGTTCTCGGGAAGAGGAGCTG 
BProt·EcoRI·R CCGGCCGAATTCCTAATTTGTTAACATTTTATCAAAGGCGG 
HProt·XhoI·F ACTGACCTCGAGATATGGGCTCCAGTGAGCAGGAAC 
HProt·EcoRI·R ACTGACGAATTCTTACATGTTTTTCAAGTGAC 
PProt·XhoI·F TCAGATCTCGAGATATGGGCAGCACCGAGGACG 
PProt·EcoRI·R ACTGCAGAATTCTTATTGCATATCGAGCGCTTTGTGC 
33K·KpnI·F AAGCTTGGTACCATGAAACCCCGCAGCATGTC 
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Table 5.1 cont. 
Oligo name Sequence (5’-3’)a 
33K·BamHI·R GCCATGGGATCCAAGGCGGGTCCGGATTCGTCC 
100K·M·F1 GCTTGTGTCATCACTGAAGAAAAAGTTTTAGCCC 
100EY·706·R1 
GGTCTGAGGGTCCAGGTATACTGCGTGCGCCTTTTTAAGGAGAAA
GTC 
100EY·706·F2 
TTCTCCTTAAAAAGGCGCACGCAGTATACCTGGACCCTCAGACCG
GC 
100EY·742·R1 
AGCTGTTGGCCCTCCGAGGGCGCTAGCGCGGAAGGCCCGGCTGCC
GAC 
100EY·742·F2 
GGCAGCCGGGCCTTCCGCGCTAGCGCCCTCGGAGGGCCAACAGCT
GC 
100EY·746·R1 
TGTGGCGGCAGCTGTTGGCGCTGCTAGCCCTGAGCCGCGGAAGGC
CCGG 
100EY·746·F2 
GGCCTTCCGCGGCTCAGGGCTAGCAGCGCCAACAGCTGCCGCCAC
AGAC 
100EY·783·R1 CCGTCAGGGGGAAGTCGACCTGCCGCTCGGATATGTCTTCCAGG 
100EY·783·F2 CCTGGAAGACATATCCGAGCGGCAGGTCGACTTCCCCCTGACGG 
100b2.EY EcoRI·F AGCTTCGAATTCGCCGCCATGGGCCTCGGAGGGCCAACAGC 
100b2.EY BamHI·R ACCGGTGGATCCGCCTCTTCTTGCCCTGGCCC 
100b3.EY EcoRI·F AGCTTCGAATTCGCCGCCATGGGAAGGCTTCCCCCTGACGGACG 
p100b1.EY·R GGTGGCGACCGGTGAGCCGCGGAAGGCCCGGCTGCCG 
CAT.SbfI.F CCTGCAGGTACCCAATACTCTTCATC 
CAT,SbfI.R CCTGCAGGTAAGCTGCAATAAACAAG 
b100K·742·F1 
GCTTGTGTCATCACTGAAGAAAAAGTGCTAGCCCAATTGCATGAA
ATTAAAAAAGC 
b100K·742·R1 
GGCAGCTGTTGGCCCTCCGAAAGCTGAGGCGCGGAAGGCCCGGC
TGCCGAC 
b100K·742·F2 
TCGGCAGCCGGGCCTTCCGCGCCTCAGCTTTCGGAGGGCCAACAG
CTGCCG 
b100K·742·R2 AGGGCGAGGGCGCGCCGCGCTGGCACTCCGGCGGCTCTTTTTGC 
100C1·F AGACCCAAGCTTCCACCATGGAAGGTAGTAGCTTCTCTG 
100C1·R TCCTTTGCTAGCCTCTTCTTGCCCTGGCCCTTC 
a Restriction enzyme sites are underlined. 
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DNA as template was digested with XhoI-EcoRI and ligated to XhoI-EcoRI digested plasmid 
pDsRed-monomer C1 (Clontech, 632466) creating plasmid pDR·pX. 
ii) Plasmid pDR.Hexon. A 2735 bp DNA fragment amplified by PCR using primers 
DRHx·XhoI·F and DRHx·EcoRI·R (Table 5.1), and plasmid pFBAV302 (Zakhartchouk et al., 
1998). DNA as a template was digested with XhoI-EcoRI enzymes and ligated to XhoI-EcoRI 
digested plasmid pDsRed-monomer C1 (Clontech, 632466) creating plasmid pDR.Hexon.  
iii) Plasmid pDR.33K. A 863 bp DNA fragment amplified by PCR using primers 33K·KpnI·F and 
33K·BamHI·R (Table 5.1), and plasmid pFBAV302 (Zakhartchouk et al., 1998). DNA as a 
template was digested with KpnI-BamHI enzymes and ligated to KpnI-BamHI digested 
plasmid pDsRed-monomer C1 (Clontech, 632466) creating plasmid pDR.33K. 
iv) Plasmid pVIII.EY. PCR was performed to amplify 664 bp product using pVIII·EY·F and 
pVIII·EY·R primers (Table 5.1) using plasmid pFBAV302 (Zakhartchouk et al., 1998) as 
template DNA. The PCR product was digested with EcoRI enzyme and cloned into plasmid 
pEYFP-N1 (Clontech, 6006-1) at the AgeI (blunt end filled-in)-EcoRI sites to create pVIII.EY.  
c) Construction of plasmids expressing protease protein 
i) Plasmid pDR.bProt. A 641 bp DNA fragment (coding BAdV-3 protease gene) amplified by 
PCR using primers BProt·XhoI·F and BProt·EcoRI·R (Table 5.1), and plasmid pFBAV302 
(Zakhartchouk et al., 1998). DNA as a template DNA was digested with XhoI-EcoRI and 
ligated to XhoI-EcoRI digested plasmid pDsRed-monomer C1 (Clontech, 632466) creating 
plasmid pDR.bProt. 
ii) Plasmid pDR.hProt. A 641 bp DNA fragment (coding HAdV-5 protease gene) using primers 
HProt·XhoI·F and HProt·EcoRI·R (Table 5.1), and plasmid pHR-5 (Lobanova et al., 2010). 
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DNA as a template was digested with XhoI-EcoRI and ligated to XhoI-EcoRI digested plasmid 
pDsRed-monomer C1 (Clontech, 632466) creating plasmid pDR.hProt. 
iii) Plasmid pDR.pProt. A 641 bp DNA fragment (coding PAdV-3 protease gene) using primers 
PProt·XhoI·F and PProt·EcoRI·R (Table 5.1), and plasmid pFPAV200 (Reddy et al., 1999). 
DNA as a template was digested with XhoI-EcoRI enzymes and ligated to XhoI-EcoRI digested 
plasmid pDsRed-monomer C1 (Clontech, 632466) creating plasmid pDR.pProt. 
d) Construction of plasmids expressing mutant 100K 
i) Plasmid pbG706A.G708A. A 111 bp DNA fragment was amplified by PCR using primers 
100K·M·F1 and100EY·706·R1 and (Table 5.1), and plasmid pcDNA.b100K DNA as a 
template. Similarly, a 460 bp DNA fragment was amplified by PCR using primers 
100EY·706·F2 and b100EY·R (Table 5.1) and plasmid pcDNA.b100K as a template. Finally, 
the two PCR products were annealed and a 528 bp DNA fragment was amplified by PCR using 
primers 100K·M·F1 and b100EY·R (Table 5.1). The final PCR product was digested with AgeI 
and ligated to AfeI-AgeI digested plasmid pb100K.EY generating plasmid pbG706A.G708A. 
ii) Plasmid pbG742A.G744A. A 216 bp DNA fragment amplified by PCR using primers 
100K·M·F1 and 100EY·742·R1 (Table 5.1) and plasmid pcDNA.b100K DNA as a template. 
Similarly, a 356 bp DNA fragment was amplified using primers 100EY·742·F2 and b100EY·R 
(Table 5.1) and plasmid pcDNA.b100K DNA as a template. Finally, the two PCR products 
were annealed and 528 bp DNA fragment was amplified by PCR using primers 100K·M·F1 
and b100EY·R (Table 5.1) The final PCR product was digested with AgeI and ligated to AfeI-
AgeI digested plasmid pb100K.EY generating plasmid pbG742A.G744A. 
iii) Plasmid pbG746A.G747A. A 225 bp DNA fragment amplified by PCR using primer 
100K·M·F1 and 100EY·746·R1 (Table 5.1) and plasmid pcDNA.b100K DNA as a template. 
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Similarly, a 348 bp DNA fragment was amplified by PCR using primers 100EY·746·F2 and 
b100EY·R (Table 5.1), and plasmid pcDNA.b100K DNA as a template PCR. Finally, the two 
PCR products were annealed and a 528 bp DNA fragment was amplified by PCR using primers 
100K·M·F1 and b100EY·R (Table 5.1). The final PCR product was digested with AgeI and 
ligated to AfeI-AgeI digested plasmid pb100K.EY generating plasmid pbG746A.G747A. 
iv) Plasmid pbG783A.G784A. A 338 bp DNA fragment was amplified by PCR using primers 
100K·M·F1 and 100EY·783·R1 (Table 5.1), and plasmid pcDNA.b100K DNA as a template. 
Similarly, a 234 bp DNA fragment was amplified by PCR using primers 100EY·783·F2 and 
b100EY·R (Table 5.1), and plasmid pcDNA.b100K DNA as a template DNA. Finally, the two 
PCR products were annealed and a 528 bp DNA fragment was amplified using primers 
100K·M·F1-b100EY·R (Table 5.1). The final PCR product was digested with AgeI and ligated 
to AfeI-AgeI digested plasmid pb100K.EY generating plasmid pbG783A.G784A. 
v) Plasmid pbG742A.G783A. A 338 bp DNA fragment was amplified by PCR using primers 
100K·M·F1 and 100EY·783·R1 (Table 5.1), and plasmid pbG742A.G744A DNA as a 
template. Similarly, a 234 bp DNA fragment was amplified by PCR using primers 
100EY·783·F2 and b100EY·R (Table 5.1), and plasmid pbG742A.G744A DNA as a template 
DNA. Finally, the two PCR products were annealed and a 528 bp DNA fragment was amplified 
using primers 100K·M·F1-b100EY·R (Table 5.1). The final PCR product was digested with 
AgeI and ligated to AfeI-AgeI digested plasmid pbG742A.G744A generating plasmid 
pbG742A.G783A. 
e) Construction of plasmids expressing nuclear localizing mutant 100K 
i) Plasmid p100b1.EY. A 2253 bp DNA fragment (coding 1-743 amino acids of BAdV-3 100K 
protein) amplified by PCR using primers b100EY·F and 100b1.EY·R (Table 5.1), and plasmid 
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pcDNA.b100K DNA as a template was digested with HindIII-AgeI and ligated to HindIII-AgeI 
digested plasmid pEYFP-N1 (Clontech, 6006-1) creating plasmid p100b1.EY. 
ii) Plasmid p100b2.EY. A 356 bp DNA fragment amplified by PCR using primers 100b2.EY 
EcoRI·F and 100b2.EY BamHI·R (Table 5.1), and plasmid pcDNA.b100K DNA as a template 
with EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 creating 
plasmid p100b2.EY. 
iii) Plasmid p100b3.EY. A 233 bp DNA fragment amplified by PCR using primers 100b3.EY 
EcoRI·F and 100b2.EY BamHI·R (Table 5.1), and plasmid pcDNA.b100K DNA as a template 
was digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 
(Clontech, 6006-1) creating plasmid p100b3.EY. 
iv) Plasmid p100.C1. A 287 bp DNA fragment (coding 766-850 amino acids of BAdV-3 100K 
protein) amplified by PCR using primers 100C1·F and 100C1·R (Table 5.1), and plasmid 
pHA.b100K DNA as a template was digested with HindIII-NheI and ligated to HindIII-NheI 
digested plasmid pGFPβGal (Wu et al., 2004) creating plasmid p100.C1. 
v) Plasmid p100.C2. A 218 bp DNA fragment (coding 766-850 amino acids of BAdV-3 100K 
protein with 789-811 amino acid coding deletion) amplified by PCR using primers 100C1·F 
and 100C1·R (Table 5.1), and plasmid pHA.b100K DNA as a template was digested with 
HindIII-NheI and ligated to HindIII-NheI digested plasmid pGFPβGal (Wu et al., 2004) 
creating plasmid p100.C2. 
5.2.4 Western blot analysis 
The cells were infected with wild-type BAdV-3 at a MOI of 5 or transfected with plasmid 
DNAs (10 μg /well). At indicated times post-infection or transfection, the cells were collected, 
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lysed and proteins analyzed by Western blot using protein specific antibodies as described 
(Kulshrestha et al., 2004). 
5.2.5 Confocal microscopy 
The cells (2x105 cells/ well) grown into 4-chambered poly-L-lysine-coated glass coverslips 
were infected with wild-type BAdV-3 at a MOI of 1 or transfected with plasmid DNA (1 µg/well). 
At 48 hrs post infection or transfection, the cells were fixed in 4% paraformaldehyde in PBS for 
30 min at room temperature before permeabilizing with 0.5% Triton X-100 in PBS for 15 min. 
The permeabilized cells were incubated with protein specific primary antibody for 60 min at 25 
°C followed by specific conjugated secondary antibody for 60 min at 25 °C. Finally, the cells were 
washed in PBS three times (10 min/wash) and counterstained with 4',6-diamidino-2-phenylindole 
(DAPI) and mounted with Citifluor AF4 mounting media. Images were captured using the 
different laser lines under laser scanning confocal microscope (Zeiss LSM410). 
5.2.6 Isolation of protease cleavage BAdV-3 mutants 
To isolate mutant BAdV-3s, we constructed full length BAdV-3 plasmids containing mutant 
BAdV-3 genomic DNA as described (Chartier et al., 1996).  
i) Plasmid pUC304aΔ100K. A 9962 bp EcoRV-NdeI DNA fragment of plasmid pUC304a+ (Du 
and Tikoo, 2010) was isolated and digested with SalI. Finally, a 6477 bp EcoRV-SalI DNA 
fragment was isolated and ligated to SmaI-SalI digested plasmid pUC18 creating plasmid 
pUC18.b100K. Next, an 894 bp DNA fragment was amplified by PCR using primers 
(CAT·SbfI·F and CAT·SbfI·R) and plasmid pBAC-lacZ (Addgene plasmid 13422) DNA as a 
template, and ligated to NheI-AfeI (blunt end repaired by T4 polymerase) digested plasmid 
pUC18.b100K to create plasmid pUC18.b100K.CAT.SbfI. A 4941 bp BamHI fragment of 
plasmid DNA pUC18.b100K.CAT.SbfI was isolated and recombined with MfeI digested 
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plasmid DNA pUC304a+ (Du and Tikoo, 2010) in E. coli BJ5183 to generate plasmid 
pUC304a.CAT.SbfI∆100K. Finally, plasmid pUC304a.CAT.SbfI∆100K was digested with 
SbfI and large fragment was self-ligated to generate plasmid pUC304a∆100K. 
ii) Plasmid pFBAV742. A 219 bp DNA fragment was amplified by PCR using primers 
b100K·742·F1 and b100K·742·R1, and plasmid pUC18.b100K DNA as a template. Similarly, 
a 631 bp DNA fragment was amplified by PCR using primers b100K·742·F2 and 
b100K·742·R2, and plasmid pUC18.b100K DNA as a template. Both PCR products were 
annealed and used as DNA template for primers b100K·742·F1-b100K·742·R2 to amplify 800 
bp DNA fragment by PCR. The final PCR product was digested with AscI and cloned in to 
AfeI-AscI digested plasmid pUC18.b100K to create plasmid pUC18100K.G742A/G744A. A 
6163 bp BglII-SalI DNA fragment of plasmid pUC18100K.G742A/G744A was isolated and 
recombined with SbfI linearized plasmid pUC304aΔ100K DNA in E. coli BJ5183 creating 
plasmid pFBAV742. 
iii) Plasmid pFBAV742/782. A 344 bp DNA fragment was amplified by PCR using primers 
100K·M·F1 and 100EY·783·R1, and plasmid pUC18100K.G742A/G744A DNA as a 
template. Similarly, a 509 bp DNA fragment was amplified by PCR using primers 
100EY·783·F2 and b100K·742·R2, and plasmid pUC18100K.G742A/G744A DNA as a 
template. Both PCR products were annealed and used as DNA template for primers 
b100K·742·F1-b100K·742·R2 to amplify 800 bp DNA fragment by PCR. The final PCR 
product was digested with AscI and cloned in to AfeI-AscI digested plasmid pUC18.b100K to 
create plasmid pUC18100K.G742A/G783A. A 6163 bp BglII-SalI DNA fragment of plasmid 
pUC18100K.G742A/G783A was isolated and recombined with SbfI linearized plasmid 
pUC304aΔ100K DNA in E. coli BJ5183 creating plasmid pFBAV742/783. 
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To isolate mutant BAdV-3, the VIDO DT1 cells were transfected with individual 
recombinant full length plasmid DNAs (10 μg/well) using LipofectamineTM 2000 (Life 
Technologies, 11668-019) as described (Reddy et al., 1999; Du and Tikoo, 2010).  
5.2.7 Virus infected cell global protein synthesis assay 
Monolayers of MDBK cells in 6 well plates were mock infected or infected with wild type 
BAV304a or mutant virus BAV742/783 at MOI of 5. At different times post infection, the cells 
were starved in media without methionine for 2 hrs before labeling with 100 Ci of [35S] 
methionine for 10 minutes. The radiolabelled cells were collected and lysed with RIPA buffer 
containing protease inhibitor cocktail. Proteins from radiolabelled cell lysates were separated by 
10% SDS-PAGE. The gel was fixed, exposed to a phosphor screen (Kodak) overnight and 
visualized on a Molecular Imager FX using Quantity One software (Bio-Rad). 
5.3 RESULTS 
5.3.1 Co-expression of 100K protein with other late proteins of BAdV-3 
Earlier (Chapter 3), we demonstrated that 100K protein is predominantly localized in the 
cytoplasm of transfected cells and interaction of 100K and 33K does not alter the localization of 
100K in co-transfected cells (Fig. 3.5). To determine the role of other BAdV-3 proteins in nuclear 
localization of 100K, we performed co-transfection experiments. As seen in figure 5.1 (A, B) 
100K-EYFP was exclusively localized to the cytoplasm of cells transfected with plasmid 
pb100K.EY (panel g). Similarly, 100K–EYFP fusion protein was exclusively localized in the 
cytoplasm of the cells co-transfected with plasmid pb100.EY+ pc.52K DNAs (panel a), 
pHA.b100K+pEY.VIII (panel b), pb100.EY+pDR.X (panel c) or pb100.EY+pDR.hexon (panels 
d). The DsRed–protease fusion protein localized to both cytoplasm and nucleus of the cells 
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transfected with plasmid pDr.bProt DNA (panel e). In contrast, co-transfection of cells with 
plasmid pb100K.EY + pDr.bProt DNAs resulted in the localization of recombinant b100K.EY 
protein in the nucleus of transfected cells without any alteration in the subcellular distribution of 
recombinant DsRed.bProt fusion protein in co-transfected cells (panels e1 and f1). These results 
suggest a role of the protease of BAdV-3 in subcellular distribution of 100K protein in cells. 
5.3.2 Cleavage of BAdV-3 100K in transfected cells 
 To further confirm the localization of 100K in cells expressing protease, the 293T cells were 
co-transfected with plasmid pb100K.EY and pDR.bProt DNAs. At 48 hrs post transfection, 
proteins from the lysates of transfected cells were separated by 12 % SDS-PAGE and analyzed by 
Western blot using antibodies recognizing the N-terminus (N100) or C-terminus (C100) of BAdV-
3 100K protein. As seen in figure 5.2, N100 (panel B) sera detected proteins of 130 kDa in cells 
co-transfected with plasmid pb100K.EY and pDsRed-C1 DNAs, and protein of 100 kDa in cells 
transfected with plasmid pb100K.EY and pDR.bProt. Similarly, C100 (panel C) sera detected 
proteins of 130 kDa in cells co-transfected with plasmid pb100K.EY + pDsRed-C1. In contrast, 
C100 sera detected a protein of 40 kDa in cells co-transfected with plasmid pb100K.EY + 
pDR.bProt. No such proteins could be detected in cells co-transfected with plasmid pb100K.EY + 
pDsRed-C1.  
5.3.3 Cleavage of 100K in BAdV-3 infected cells  
 To determine if 100K protein is also cleaved in BAdV-3 infected cells, the MDBK cells were 
infected with BAdV-3 at an MOI of 5. At 48 hrs post infection, the proteins from the lysates of the 
infected cells were separated by 15 % SDS-PAGE and probed in Western blot using anti-100K 
sera. As seen in figure 5.3 N100K sera detected the proteins of the 130 kDa (panel A) in BAdV-3 
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Figure 5.1 Subcellular distribution of BAdV-3 100K protein in co-transfected cells. (A) 
Schematic diagram of plasmid DNAs. The origin of DNA BAdV-3 100K ( ), Hexon ( 
), 52K ( ), X ( ), protease ( ) and EYFP ( ), HA tag ( ) DsRed ( 
) is depicted. (B) Vero cells cotransfected with plasmid DNAs pc.52K + pb100.EY (panel a), 
pVIII.EY + pHA.b100K (panel b), pDR.pX + pb100K.EY (panel c), pDR.Hexon + pb100K.EY 
(panel d), pDR.bProt + pb100K.EY (panel f), or transfected with plasmid pDR.bProt (panel e) or 
pb100K.EY (panel g). The localization of protein was visualized by direct fluorescence (panels 
a2, b1, c, d, e, f, g) or indirect immune fluorescence (panels a1, b2) using anti-52K serum (panel 
a1) or anti-HA monoclonal antibody (panel b2). Nuclei were stained with DAPI in each panel. A 
merge of the images is shown. 
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infected cells. In contrast, the C100K sera detected a protein of 15 kDa in BAdV-3 infected cells 
(panel B). No such proteins could be detected in the mock-infected MDBK cells (panel A, B).  
5.3.4 Analysis of BAdV-3 100K protein sequence for potential protease cleavage sites 
 Based on the cleavage of adenovirus structural proteins (Mangel et al., 2003) by adenovirus 
encoded protease, at least two consensus protease cleavage sequences (M/I/L)XGX-G and 
(M/I/L)XGG-X  have been identified (Diouri et al., 1996). Consensus adenoviral protease cleavage 
sequences are composed of glycine residues essential for the cleavage of substrate proteins 
(Ruzindana-Umunyana et al., 2002). Analysis of amino acid sequence of BAdV-3 100K identified 
four potential protease cleavage sites (Table 5.2).  
5.3.5 Mutational analysis of potential protease cleavage site(s) of BAdV-3 100K protein  
 To further characterize the cleavage of 100K protein by BAdV-3 protease, we constructed 
plasmids (pbG706A.G708A, pbG742A.G744A, pbG746A.G747A, pbG783A.G784A and 
pbG742A.G783A) encoding mutant 100K in which the essential glycine residues of potential 
protease cleavage sites of 100K were substituted with alanine residues (Fig. 5.4). Cleavage of 
mutant 100K proteins by adenovirus protease was analyzed by Western blot of the lysates of the 
cells co-transfected with plasmid pDR.bProt and individual plasmid DNAs encoding wild-type or 
mutant 100K protein. As seen in figure 5.4, anti-GFP antibody detected a major protein of 40 kDa 
and a minor protein of 36 kDa in the cells expressing b100K.EY fusion protein and protease. 
Similar proteins were detected in cells co-expressing protease and mutant b100K.706/708 or 
mutant b100K.746/747 proteins using anti-GFP antibody (Fig. 5.4). Moreover, cleavage of 100K 
appeared efficient in cells expressing protease as no uncleaved 100K protein could be detected 
(Fig. 5.4). In contrast, anti-GFP antibody detected only 36 kDa protein in cells expressing protease 
and mutant b100K.742/744 protein (Fig. 5.4). In addition, cleavage of 100K appeared inefficient 
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Figure 5.2 Cleavage of BAdV-3 100K protein in transfected cells. (A) Schematic diagram of 
plasmid DNAs. The origin of BAdV-3 100K ( ), BAdV-3 protease ( ) and DsRed ( 
) DNA is depicted. (B) Proteins from the lysates of 293T cells co-transfected with the indicated 
plasmid  were fractionated by 15 % SDS-PAGE, transferred to nitrocellulose and probed in 
Western blot using anti-100K sera: N100 (panel B) or C100 (panel C). Filled arrows indicate 
mature b100K-EY fusion protein and empty arrows indicates the cleaved product.  
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Figure 5.3 Cleavage of 100K protein in BAdV-3 infected cells. Proteins from the lysate of 
BAdV-3 infected or mock infected MDBK cells harvested at 48 hrs post infection (panel A,B) 
were separated by 15% SDS-PAGE, transferred to nitrocellulose  and probed in Western blot using 
anti-100K specific sera; N100 (panel A) or C100 (panel B) antibodies. The detected proteins are 
indicated by arrows. 
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Table 5.2 List of potential protease cleavage sequences in 100K protein of BAdV-3 
Potential cleavage sequence Mutations 
704-KKGHGV-709 G706A, G708A 
740-FRGSGL-745 G742A, G744A 
743-SGLGGP-748 G746A, G747A 
781-IRGGGR-786 G783A, G784A 
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as uncleaved mutant 100K could be detected in these cells (Fig. 5.4). Only 40 kDa protein could 
be detected in the cell lysates of the cells cotransfected with the plasmid DNA b100K.783/784 and 
pDR.bProt (Fig. 5.4). No cleaved fragments can be detected from the cell lysate cotransfected with 
the plasmid DNA b100K.742/783 and pDR.bProt (Fig. 5.4).  
 To further characterize the cleavage of BAdV-3 100K, the subcellular localization of 
protease cleavage site mutant 100K proteins was analyzed in cells co-expressing BAdV-3 protease 
by confocal microscopy. As seen in figure 5.5 wild-type (panel a) or single protease cleavage site 
mutant 100K proteins (panel b, c) localized predominantly in the nucleus of transfected cells co 
expressing protease. In contrast, double protease cleavage site mutant 100K localizes 
predominantly to the cytoplasm of cells co-expressing protease (panel d). 
 To confirm which cleavage fragment of 100K localized to nucleus, we constructed three 
plasmids encoding mutant 100K individually fused in frame to the gene encoding EYFP (Fig. 
5.6A). The Vero cells were co-transfected with individual 100K mutant plasmid DNA and plasmid 
p100b2.EY DNA, and examined by direct fluorescence. As seen in figure 5.6B, EYFP fused to 
either amino acid 744-850 (cleavage fragment 1; panel b) or amino acid 785-850 (cleavage 
fragment 2; panel c) of 100K is predominantly localized to the nucleus of transfected cells. 
However, EYFP fused to amino acids 1-743 of 100K protein localized to the cytoplasm of the 
transfected cells (panel a).  
 Taken together, these results suggest that adenoviral protease recognizes two protease 
cleavage sites (amino acids 740-745 & 781-786) at the C-terminus portion of 100K protein of the 
BAdV-3. Moreover, our results suggest that cleaved C-terminus of 100K localizes to the nucleus. 
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Figure 5.4 Expression of BAdV-3 100K cleavage of mutant protein in co-transfected cells. 
(A) Schematic diagram of plasmid DNAs. The origin of DNAs is depicted. The substituted 
alanines for glycines in predicted protease cleavage sites are underlined. The name of the plasmid 
is on the right side of the panel. The name of the protein is on the left side of the panel. (B) Proteins 
from the lysates of indicated plasmid DNA transfected 293T cells harvested at 48 hrs post 
transfection were separated by 15% SDS-PAGE, transferred to nitrocellulose and probed in 
Western blot using anti-GFP monoclonal antibody. Filled arrows indicate mature 100K-EY fusion 
protein and empty arrows indicates the cleaved 100K-EY fusion protein. 
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5.3.6 C-terminus of 100K contain nuclear localization signal 
 Analysis of BAdV-3 100K protein sequence by PSORT II computer program (Horton et al., 
2007) identified a potential bipartite nuclear localization signal at amino acids 789 to 811. To 
determine if amino acids 789-811 containing basic residues are important for nuclear transport, 
amino acids 766-850 or 766-850 (containing deletion of amino acid 789-811) were individually 
fused in-frame to the N-terminus of a green fluorescent protein-β galactosidase (GFPβGal) fusion 
to produce chimeric bNLS-GFPβGal and bNLSdel-GFPβGal. As seen in figure 5.7B, bNLS-
GFPβGl localized predominantly in the nucleus of transfected cells. In contrast, similar to 
GFPβGal (Wu et al., 2004) bNLSdel-GFPβGal fusion protein localized predominantly to the 
cytoplasm of the transfected cells. 
To determine if 100K protein can interact with the importins, we performed the GST-pull 
down assay. GST alone or GST fused to importin α1 α3, α7 or β1 was incubated individually with 
in vitro transcribed/translated [35S] labeled 100K. The bound proteins were separated by 10 % 
SDS-PAGE and visualized by autoradiography. As seen in figure 5.7C in vitro translated 100K 
interacted with GST-importin α3 fusion protein. No interaction was detected between in vitro 
synthesized 100K with GST alone or GST fused to importin α1, α7 or β1. 
5.3.7 Cleavage of 100K protein in other Mastadenoviruses  
 To determine if the cleavage of 100K protein is conserved in other members of 
Mastadenoviruses, we constructed plasmids expressing 100K protein of HAdV-5 
(pHA.h100K.EY) or porcine adenovirus (PAdV)-3 (pHA.p100K.EY) as EYFP fusions proteins, 
and DsRed fusion proteins. Proteins from the lysates of the cells co-transfected with plasmid DNAs 
were separated by 12 % SDS-PAGE and probed in Western blot using anti-GFP sera. As expected 
(Fig. 5.8, panel A), anti-GFP sera detected a 40 kDa major cleavage product and a minor band of 
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Figure 5.5 Subcellular distribution of BAdV-3 100K cleavage site mutant protein in co-
transfected cells. Vero cells cotransfected with indicated plasmid DNAs were analyzed by direct 
fluorescence at 48 hrs post transfection using Zeiss LSM 5 laser scanning confocal microscope. 
The name of the plasmid is on the right of the panel. 
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35 kDa in cells cotransfected with plasmid pHA.b100K.myc.EY + pDR.bProt b) plasmids 
expressing protease protein of HAdV-5 (pDR.hProt) or PAdV-3 (pDRpProt) as DNAs. No such 
cleavage product could be detected in cells cotransfected with plasmid pHA.h100K.myc.EY + 
pDR.hProt or pHA.p100K.myc.EY+pDR.pProt DNAs (Fig. 5.8, panel A). These results are 
suggestive of the cleavage of 100K protein of BAdV-3 only and not the other adenoviruses in 
transfection assays. 
 Secondly, the cells expressing BAdV-3 100K-EYFP fusion protein were co-transfected with 
plasmid pDR.bProt, pDR.hProt or pDR.pProt DNAs and analysed by Western blot. As seen in 
figure 5.8 (panel B), proteins of 40 kDa and 36 kDa were detected in cells expressing BAdV-3 
100K-EYFP fusion proteins and protease encoded by BAdV-3, HAdV-5, or PAdV-3. No such 
proteins could be detected in cells expressing BAdV-3 100K-EYFP fusion protein.  
5.3.8 Isolation of recombinant BAdV-3 expressing protease cleavage site(s) mutant 100K 
protein. 
 In order to determine the role of 100K cleavage in BAdV-3 replication, we generated 
protease cleavage resistant mutant viruses (Fig. 5.9, panel A). First recombinant virus BAV742 
contained substitution of amino acid 742 and 744 from G to A in potential protease cleavage site 
1 of 100K. The second recombinant BAV742/783 contained substitution of amino acids 742, 746, 
783 and 784 from G to A in potential protease cleavage site 2 of 100K. Introduction of these amino 
acid substitutions altered the potential protease cleavage site of 100K, which was confirmed by 
Western blot. As seen in figure 5.9 (panel B), anti-100K antibody (C100) detected a protein of 15 
kDa in BAV304a infected cells. No such protein could be detected in cells infected with BAV742 
or BAV742/783. 
 To determine viral gene expression in mutant virus infected cells, the expression of selected  
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Figure 5.6 Intracellular localization of mutant 100K proteins. (A) Schematic diagram of 
plasmid DNAs. The origin of DNAs is depicted. The amino acid numbers of 100K are depicted. 
The name of the plasmid is on the right side of the panel. (B) Vero cells co-transfected with 
indicated plasmid DNAs were analyzed by direct fluorescence at 48 hrs post transfection using 
Zeiss LSM 5 laser scanning confocal microscope.  
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Figure 5.7 Subcellular distribution of nuclear localization signal (NLS) mutant 100K. (A) 
Schematic diagram of plasmid DNA. The origin of DNAs is depicted. The numbers represent the 
amino acids of 100K. The amino acid sequence of potential bipartite NLS is depicted. (B) Vero 
cells transfected with indicated plasmid DNAs were analyzed by direct fluorescence microscopy 
48 hrs post transfection using Zeiss LSM 5 laser scanning confocal microscope. (C) GST pull 
down of radiolabelled [35S] 100K protein with GST alone or GST importin fusion with β1, α1, α3 
and α7. 
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Figure 5.8 Cleavage of adenovirus 100K by different proteases. (A) Proteins from the lysates 
of 293T cells transfected with indicated plasmid DNAs and harvested at 48 hrs post transfection 
were separated by 15% SDS-PAGE, transferred to nitrocellulose and probed in Western blot using 
anti-GFP monoclonal antibody. Filled arrows indicate mature b100K-EY, h100K-EY or p100K-
EY fusion protein and empty arrows indicates the cleaved product. (B) 293T cells transfected with 
indicated plasmid DNAs and harvested at 48 hrs post transfection were separated by 15% SDS-
PAGE, transferred to nitrocellulose and probed in Western blot using anti-GFP monoclonal 
antibody. Filled arrows indicate mature b100K-EY fusion protein and empty arrows indicates the 
cleaved product. 
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Figure 5.9 Analysis of mutant 100K BAdV-3. (A) Schematic diagram of mutant BAdV-3 
genomes. The origin of DNAs is depicted. The horizontal arrows depict the direction of 
transcription. The name recombinant BAdV-3 is on the right of the panel. The name of the full 
length plasmid is on the left of the panel. The amino acid number of 100K are depicted along 
mutant identified protease cleavage sequence. The alanines substituted for glycines are shown in 
bold and underlined. (B) Proteins from the lysates of mock infected or virus infected VIDO DT1 
(Du and Tikoo, 2010) cells harvested at 48 hrs post infection were separated by 15% SDS-PAGE, 
transferred to nitrocellulose and probed in Western blot using anti-100K (C100) sera. 
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early (DNA binding protein) and late genes (33K) was analyzed by Western blot. As seen in figure 
5.10, the 33K protein and DBP were expressed in equal amounts in the wild type and mutant 
viruses. 
5.3.9 Cell associated vs. secreted 
 To assess whether global cellular protein synthesis is affected during infection with 
BAV304a and BAV742/783 viruses, cellular protein synthesis assay was performed. The results 
indicated a similar level of protein synthesis in the BAV304a and BAV-742/783 virus infected 
cells, suggesting no change in the level of protein synthesis due to mutations of the protease 
cleavage sites of 100K protein (Fig. 5.11).  
 To determine if inhibition of cleavage of 100K affected the virus growth, we determined the 
ability of mutant viruses to grow in MDBK cells. Virus infected cells were harvested at indicated 
times post infection, freeze thawed five times and the cell lysates were analyzed for virus titer by 
a TCID50 assay. As seen in figure 5.12A, all the three viruses were growing at similar titers at 
different time points post-infection of MDBK cells. Interestingly, there was a log difference 
between virus titers between BAV304a and BAV-742/783 (Fig. 5.12B). The results of this assay 
suggests possible role of cleavage in the release of the BAdV-3 from infected cells. 
5.4 DISCUSSION 
 Production of mature infectious adenovirus particle requires the cleavage of some virus 
structural proteins by virus specific protease (Diouri et al., 1996). Although cleavage of adenovirus 
non-structural protein by virus specific recombinant protease has been reported in vitro 
(Ruzindana-Umunyana et al., 2002), no cleavage of an adenovirus non-structural protein by virus 
protease has been reported in-vivo. This may partly be due to the fact that adenovirus protease 
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appears to be activated only in assembled virions (Ding et al., 1996), which do not contain non- 
structural proteins (Berk, 2007). Here, we report the cleavage of 100K, a non-structural protein of  
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Figure 5.10 Expression of late and early genes in the 100K protease cleavage mutant viruses. 
Proteins from the lysates of VIDO DT1 cells mock infected or infected with indicated viruses were 
harvested at 48 h post infection, separated by 15% SDS-PAGE and probed in Western blot using  
anti-33K antibody (panel A) or anti-DBP serum (panel B) The molecular weight of protein markers 
in kDa. Are depicted on the left of the panel. Beta-actin was used as the loading control for protein 
amount. 
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Figure 5.11 Effect of 100K protein cleavage mutant virus on global translation. Confluent 
monolayers of MDBK cells were infected with mutant or wild-type BAdV-3. At different times 
post infection, the cells were labelled with radiolabelled methionine for 1 hour. Cells were 
harvested and analyzed by SDS PAGE and autoradiography for global translation. 
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Figure 5.12 Analysis of 100K protein cleavage mutant virus titers. Single step growth curve. 
Confluent monolayers of MDBK cells were infected with mutant or wild-type BAdV-3. At 
different times post infection, the cells and the media was collected together (panel A) or separated 
(panel B), freeze thawed and virus was titrated as described (Reddy et al., 1998; Kulshreshtha et 
al., 2004).  
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bovine adenovirus-3 by viral protease in transfected and BAdV-3 infected cells. Moreover, we 
demonstrate that cleavage of BAdV-3 100K appears essential for nuclear localization of 100K but 
not for efficient virus replication. Our study suggests the need for investigation in the protease 
activation mechanism. 
The 100K protein of BAdV-3 localizes to the nucleus in infected cells. Analysis of 100K 
protein predicted a bipartite nuclear localization at amino acids 789-811, which is sufficient to 
localize GFPβGal fusion protein (Wu et al., 2004) to the nucleus in transfected cells. However, 
BAdV-3 100K protein localized to cytoplasm in transfected cells suggesting that potential NLS is 
not functional when 100K is expressed alone in transfected cell. In contrast, 100K of HAdV-2/5 
localizes to nucleus in transfected cells (Cuesta et al., 2004; Koyuncu and Dobner, 2009). 
Interestingly, co expression of 100K with protease but not hexon localized 100K in the nucleus of 
transfected cells. Although pVI (Wodrich et al., 2003) or 100K (Hong et al., 2005) of adenovirus 
has been reported to be required for partial nuclear localization of hexon, there appears no report 
suggesting the requirement of adenovirus protease for nuclear transport of an adenovirus protein. 
Recent studies have demonstrated significant variation in the structure, sub cellular 
localization and function of adenovirus protein homologs encoded by different members of 
Mastadenoviruses (Stracker et al., 2005; Blanchette et al., 2013; Cheng et al., 2013). Several lines 
of evidence suggest significant differences may exist in 100K encoded by different 
Mastadenoviruses. First, analysis of amino acid sequences identified two consensus protease 
cleavage sites (amino acid 740-745 and amino acid 781-786) in 100K protein encoded by BAdV-
3 but not in 100K protein encoded by HAdV-5 (Fig. 5.8; panel A) or PAdV-3 (Fig. 5.8; panel A). 
Secondly, the protease encoded by BAdV-3 can cleave BAdV-3 100K protein in transfected cells. 
Moreover, cleavage of BAdV-3 100K protein could be detected in infected cells. Thirdly, cleavage 
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of HAdV-5 or PAdV-3 100K proteins by proteases encoded by HAdV-5 or BAdV-3 could not be 
detected in transfected cells. Fourthly, proteases encoded by HAdV-5 or PAdV-3 also cleave 
BAdV-3 100K in transfected cells. Finally, BAdV-3 100K cleavage appears specific as cleavage 
of mutant 100K containing altered protease cleavage sites could not be detected in transfected cells 
co-expressing protease. 
The current model of adenovirus protease activation suggest the requirement of two viral 
cofactors namely C-terminal 11 amino acids of pVI and adenoviral DNA (Mangel et al., 1993). 
Adenoviral protease is synthesized in the inactive form and can only be activated in the presence 
of cofactors in the nucleus of the adenovirus infected cells (Mangel et al., 2003). Our findings 
suggest the important aspect of adenoviral protease activation in the absence of cofactors and in 
the co-transfected cells. Interestingly, BAdV-3 100K can be cleaved by HAdV-5 (Fig. 5.8B) and 
PAdV-3 (Fig. 5.8B) proteases but the efficiency varies for different sites among proteases. 
Cleavage of BAdV-3 100K protein by protease in the plasmid cotransfected cells can serve as the 
basis for further studies. 
Although BAdV-3 100K protein alone is predominantly localized in the cytoplasm of the 
transfected cells, the co-expression with protease localizes 100K predominantly to the nucleus of 
the transfected cells. Further analysis suggest that C-terminal protease cleaved fragments of 100K 
are predominantly localized in the nucleus of the transfected cells co-expressing protease with wild 
type 100K or single protease cleavage site mutant 100K but not with double protease cleavage site 
mutant of 100K-EYFP fusion protein. It is possible that C-terminal cleavage fragment of 100K-
EYFP fusion protein is passively diffused into the nucleus. Alternatively, it is possible that C-
terminal cleavage fragments contain nuclear localization signal(s) and are actively transported to 
the nucleus using importin α/β import pathway. Support for this comes from the fact that a) 
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analysis of the protein sequence identified a bipartite NLS (amino acid 789-811; figure5.7B) in C-
terminal region of BAdV-3 100K protein, b) amino acid 744-850 were sufficient to direct the 
nuclear import of a predominantly cytoplasmic fusion protein (GFPβGal), c) amino acid 744-850 
containing deletion of amino acid 899-811 were not sufficient to direct the nuclear import of a 
predominantly cytoplasmic fusion protein (GFPβGal). Surprisingly, despite the presence of NLS, 
100K is not transported to the nucleus in transfected cells. It is possible that other viral protein (s) 
may be required for transport of 100K to nucleus. However, co-expression of 100K with other 
BAdV-3 late proteins except protease does not alter the localization of 100K. Alternatively, it is 
possible that 100K protein is retained in the cytoplasm by interacting with a cellular protein. 
Interestingly, the central region (amino acid 498-588) of 100K interacts with cytoplasmic dynein 
light chain Tctex 1 (DYNLT1) protein (Chapter 4). Interaction of viral structural proteins including 
adenovirus hexon with cytoplasmic dynein mediates transport of the virus across the cytoplasm of 
infected cells (Bremner et al., 2009). Since 100K is a non-structural protein, we hypothesize that 
interaction of 100K protein with DYNLT1 helps to retain 100K in the cytoplasm to perform an 
important function presumably the inhibition of cellular mRNA translation (Cuesta et al., 2000) 
and enhancement of adenovirus late mRNA translation (Xi et al., 2004). It is interesting to note 
that a) amino acid 1-726 of 100K are required for regulating cellular and late adenoviral mRNA 
translation (Cuesta et al., 2004; Xi et al., 2004) and b) both regulation of translation (Zhang et al., 
1994) and cleavage of BAdV-3 100K occur at late phase of adenovirus infection. Interaction of 
HAdV-2 E3 nonstructural protein 19K with components of microtubules has been suggested to 
retain class I major histocompatibility complex molecules when complexed with gp19 into 
endoplasmic reticulum thus down regulating cell surface expression of MHC-1 proteins (Dahllof 
et al., 1991). 
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 The significance of our finding about cleavage of 100K in BAdV-3 infection and localization 
of C-terminal cleavage fragment(s) to nucleus is not clear. Our results suggest that cleavage of 
100K at amino acid 742 and 783 is not essential for efficient replication and generation of progeny 
BAdV-3. Since the cleavage is detected at late times post BAdV-3 infection, we hypothesized that 
it may have a role in the events occurring late in BAdV-3 infection including altered ribosomal 
RNA processing (Paterson, 2010), inhibition of cellular mRNA translation (Lisanework and 
Tikoo, manuscript in preparation), or release of virus. However, there was no difference in 
ribosomal RNA processing or cellular mRNA translation in cells infected with wild type or mutant 
BAdV-3 expressing protease cleavage resistant 100K (data not shown). In contrast, although WT 
and protease cleavage mutant BAdV-3s grew to similar titers, we observed one log less virus in 
the supernatant of cells infected with protease cleavage mutant compared to wild type BAdV-3. It 
is possible that nuclear localization of C-terminal cleavage fragment of 100K may help in lysis of 
infected cells helping in the release of progeny virus in media. The cleavage of 100K protein in 
BAdV-3 infected cells is unique event and appear to be absent in the HAdV-5 and PAdV-3 
infection process. 
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6.0 GENERAL DISCUSSION AND CONCLUSIONS 
 Earlier reports indicate that adenovirus 100K protein is involved a) in enhancing the 
translation of late adenoviral mRNAs by ribosomal shunting mechanism, b) in inhibiting the 
translation of capped cellular mRNAs, and c) in trimerization of adenovirus hexon protein (Cuesta 
et al., 2000; Hong et al., 2005; Xi et al., 2005). Some of the identified functions require interaction 
of adenoviral 100K protein with cellular (Xi et al., 2005) and viral protein(s) (Hong et al., 2005; 
Kulshreshtha and Tikoo, 2008). Although, the members of the Adenoviridae family encode the 
homologs of non-structural protein 100K with similar genomic organization (Davison et al., 2003), 
the proteins sequences have shown variable (27.6 % to 52.1%) homologies (Reddy et al., 1998). 
Since significant differences have been reported to exist in structure and function of adenovirus 
protein homologs showing significant homology (Blanchette et al., 2013;  Cheng et al., 2013; ; 
Stracker et al., 2005), we sought to analyze BAdV-3 100K protein in detail. Thus, the primary aim 
of this work was to characterize 100K protein and elucidate its interaction with other viral/ cellular 
proteins. 
Using antisera raised in rabbits against peptides representing 100K protein (N terminus or 
C-terminus), we detected a protein of 130 kDa at 24 to 48 hrs post-infection. Interestingly, 130 
kDa protein could also be detected as a doublet at 36 and 48 hrs post-infection. Presence of an 
extra band, also reported in HAdV-2 infected cells (Hong et al., 2005) at later time point post-
infection is suggestive of the post-translational modification like methylation (Koyuncu and 
Dobner, 2009) or phosphorylation (Xi et al., 2005) of the 100K protein. 
Like HAdV-5 (Koyuncu and Dobner, 2009), the 100K protein is localized to the nucleus and 
cytoplasm of BAdV-3 infected cells. However, unlike HAdV-5 100K protein (Koyuncu and 
Dobner, 2009), BAdV-3 100K-EYFP fusion protein localized exclusively to the cytoplasm of 
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transfected cells. Interestingly, 100K-EYFP fusion protein localized to nucleus of BAdV-3 
infected cells suggesting that nuclear localization of 100K may require other viral or cellular 
proteins in infected/transfected cells. Although viral proteins known to interact with adenoviral 
100K did not affect the localization of 100K protein, surprisingly co-expression of 100K with 
adenoviral protease localized BAdV-3 100K protein to the nucleus in co-transfected cells. Analysis 
of transfected cells revealed that protease cleaves 100K protein at two consensus protease cleavage 
sites and only C-terminal cleaved fragments of 100K containing bipartite nuclear localization 
signals are localized to nucleus.  
Like HAdV-5 (Cuesta et al., 2000; Xi et al., 2005), the cellular mRNA translation (Ayalew 
and Tikoo, unpublished results) and ribosomal processing (Paterson, 2010) is inhibited at late times 
post BAdV-3 infection. Interestingly, the cleavage of 100K also appears to occur at late times (36-
48 hrs) post BAdV-3 infection. However, analysis of recombinant BAdV-3 expressing protease 
cleavage mutant suggested that cleavage of 100K does not appear to be essential for the replication 
of BAdV-3 or events observed at late times post BAdV-3 infection including inhibition of cellular 
mRNA translation and ribosomal processing. Nevertheless, though protease cleavage mutant grew 
to similar titers to WT BAdV-3, less virus (1 log) was observed in supernatant of protease cleavage 
mutant infected cells than in supernatant of Wt BAdV-3 infected cells. It is possible that nuclear 
localization of C-terminal cleavage fragment of 100K may help in lysis of infected cells helping 
in the release of progeny virus in media. Virus release from the infected cells is the results of the 
cleavage of cytokeratin 18 by viral protease (Chen et al., 1993), action of ADP (Tollefson et al., 
1996) and interaction of accumulated fiber with CAR (Walters et al., 2002).  
Protein-protein interactions have been reported in adenovirus infected cells (Wickham et al., 
1993; Berk, 2005; Bremner et al., 2009; Arnberg. 2012). The involvement of 100K protein in 
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different steps of adenovirus replication (Cepko and Sharp, 1982; Cuesta et al., 2000; Hong et al., 
2005; Xi et al., 2005) may require protein-protein interactions. Like other adenovirus proteins, 
adenovirus 100K protein is reported to interact with hexon (Frost and Williams, 1978; Cepko and 
Sharp, 1982). Using several assays (yeast two-hybrid, GST pull-down and co-
immunoprecipitation assays), earlier our laboratory demonstrated that 100K interacts with 33K 
protein in BAdV-3 infected cells (Kulshreshtha and Tikoo, 2008). We reconfirmed these results 
using bimolecular fluorescence complementation assays (BiFC). Using mutant BAdV-3 100K 
proteins, we demonstrate that the 33K protein interacting region of 100K appears to be localized 
between amino acids 624-637. Several attempts to isolate mutant BAdV-3 expressing mutant 100K 
containing deletion of 33K protein interacting region proved futile suggesting the essential role of 
this interaction (100K-33K) or interacting region (AA 624-637) of 100K protein in the viral life 
cycle. It is also possible that deletion of 13 amino acid interacting region of 100K might alter the 
100K folding and/or other unidentified function of 100K. Further experiments are in progress to 
isolate and analyze recombinant BAdV-3 expressing mutant 100K (containing point 
mutation/substitution point mutation) protein. 
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